\u00a0
\nPlanet 13 Holdings Inc. (\u201cP13\u201d or the \u201cCompany\u201d) was incorporated under the Canada Business Corporations Act on April 26, 2002 and continued under the British Columbia Business Corporations Act on September 24, 2019.
\n\u00a0
\nThe Company is a vertically integrated cultivator and provider of cannabis and cannabis-infused products that is licensed under the laws of the States of Nevada, California, and Florida with a license lottery win-result in Illinois. We are licensed in these jurisdictions as follows: Nevada licenses for cultivation ( medical and adult-use), Nevada licenses for production ( medical and adult-use), Nevada dispensary licenses ( medical and adult-use), Nevada licenses for distribution ( active, conditional), adult-use dispensary license in California, distribution license in California, Medical Marijuana Treatment Center license in Florida (unlimited medical dispensaries, cultivation and processing) and lottery win for an adult-use dispensary license in Illinois. As of March 2, 2022, by way of acquisition and in addition to the licenses listed above, we added California cultivation licenses ( medical and adult-use), California cultivation nursery license, California distribution license, California license for adult-use manufacture, and pending California license for cultivation packaging.
\n\u00a0
\nP13 is a public company which is listed on the Canadian Securities Exchange (\u201cCSE\u201d) under the symbol PLTH and on the OTCQX exchange under the symbol \u201cPLNHF\u201d.
\n\u00a0
\nThe Company\u2019s registered office is located at Bentall 5, 550 Burrard Street, Suite 2501, Vancouver, BC V6C 285, and the head office address is 2548 W. Desert Inn Road, Las Vegas, NV 89109.
\n\u00a0
\nWhile cannabis and CBD-infused products are legal under the laws of several U.S. states (with varying restrictions applicable), the United States Federal Controlled Substances Act classifies all \u201cmarijuana\u201d as a Schedule I drug, whether for medical or recreational use. Under U.S. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States, and a lack of safety for use under medical supervision.
\n\u00a0
\nThe federal government currently is prohibited from prosecuting businesses that operate in compliance with applicable state and local medical cannabis laws and regulations; however, this does not protect adult use cannabis. In addition, if the federal government changes this position, it would be financially detrimental to the Company.
\n "}]},{"name":"rpt:f-362","factDimensions":{"xbrl:concept":"us-gaap:BasisOfAccounting","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| 2. Basis of presentation |
\u00a0
\nThese consolidated financial statements reflect the accounts of the Company and have been prepared in accordance with generally accepted accounting principles in the United States of America (\u201cGAAP\u201d) and pursuant to the rules and regulation of the U.S. Securities and Exchange Commission (\u201cSEC\u201d) for all periods presented. These consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will continue in operation for the foreseeable future and, accordingly, will be able to realize its assets and discharge its liabilities in the normal course of operations as they come due, under the historical cost convention except for certain financial instruments that are measured at fair value, as detailed in the Company\u2019s accounting policies.
\n\u00a0
\nFailure to arrange adequate financing on acceptable terms and/or achieve profitability may have an adverse effect on the financial position, results of operations, cash flows and prospects of the Company. These consolidated financial statements do not give effect to adjustments to assets or liabilities that would be necessary should the Company be unable to continue as a going concern. Such adjustments could be material. These consolidated financial statements are presented in U.S. dollars, which is also the Company\u2019s and its subsidiaries\u2019 functional currency.
\n\u00a0
\nThese consolidated financial statements were authorized for issuance by the Board of Directors of the Company on March 23, 2023.
\n\u00a0
\n \n \ni) Basis of consolidation
\n\u00a0
\nThe accompanying consolidated financial statements include the accounts of the Company and all subsidiaries. Subsidiaries are entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest entity. Subsidiaries are fully consolidated from the date control is transferred to the Company and are deconsolidated from the date control ceases. All intercompany accounts and transactions have been eliminated upon consolidation. The consolidated financial statements include all the assets, liabilities, revenues, expenses and cash flows of the Company and its subsidiaries after eliminating intercompany balances and transactions.
\n\u00a0
\nThese consolidated financial statements include the accounts of the Company and the following entities which are subsidiaries of the Company:
\n\u00a0
\n \nSubsidiaries as at December 31, 2022 | \u00a0 | Jurisdiction of Incorporation | \u00a0 | Ownership Interest 2022 | \u00a0 | Ownership Interest 2021 | Nature of Business | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
MM Development Company, Inc. (\"MMDC\") | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Nevada license holding company; vertically integrated cannabis operations | ||
BLC Management Company LLC | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Management/holding company | ||
LBC CBD LLC (\"LBC\") | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | CBD retail sales and marketing | ||
Newtonian Principles Inc. | \u00a0 | California, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | California license holding company; cannabis retail sales | ||
Crossgate Capital U.S. Holdings Corp. | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 0 | % | Holding company | ||
Next Green Wave, LLC | \u00a0 | California, USA | \u00a0 | 100 | % | \u00a0 | 0 | % | California license holding company; cannabis cultivation and processing | ||
Planet 13 Illinois, LLC | \u00a0 | Illinois, USA | \u00a0 | 49 | % | \u00a0 | 49 | % | Illinois license holding company | ||
BLC NV Food, LLC | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Holding company for By The Slice LLC | ||
By The Slice, LLC | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Subsidiary of BLC NV Food, LLC; restaurant and retail operations | ||
Planet 13 Chicago, LLC | \u00a0 | Illinois, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Holding company | ||
Planet 13 Florida, Inc. | \u00a0 | Florida, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Florida license holding company | ||
Club One Three, LLC | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | N/A | Inactive |
\u00a0
\nii) Variable interest entities
\n\u00a0
\nA variable interest entity (\u201cVIE\u201d) is an entity that does not have sufficient equity at risk to finance its activities without additional subordinated financial support or is structured such that equity investors lack the ability to control the entity\u2019s activities or do not substantially participate in the gains and losses of the entity. Upon inception of a contractual agreement, and thereafter, if a reconsideration event occurs, the Company performs an assessment to determine whether the arrangement contains a variable interest in an entity and whether that entity is a VIE. The primary beneficiary of a VIE is the party that has both the power to direct the activities that most significantly impact the VIE\u2019s economic performance and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. Where the Company concludes that it is the primary beneficiary of a VIE, the Company consolidates the accounts of that VIE.
\n\u00a0
\niii) Functional currency
\n\u00a0
\nThese consolidated financial statements are presented in U.S. dollars (\u201cUSD\u201d), which is the Company\u2019s and its subsidiaries functional currency.
\n\u00a0
\n \n \nForeign currency transactions are remeasured to the respective functional currencies of the Company\u2019s entities at the exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies are measured to functional currency at the foreign exchange rate applicable at the statement of balance sheets date. Non-monetary items are carried at historical rates. Non-monetary items carried at fair value denominated in foreign currencies are remeasured to the functional currency at the date when the fair value was determined. Realized and unrealized foreign exchange gains and losses are recognized through profit or loss.
\n\u00a0
\niv) Emerging growth company
\n\u00a0
\nThe Company is an \u201cEmerging Growth Company\u201d, as defined in Section 2(a) of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), as modified by the Jumpstart Our Business Startups Act of 2012 (the \u201cJOBS Act\u201d), and it has taken advantage of certain exemptions that are not applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
\n\u00a0
\nFurther, Section 102(b) (1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had\u00a0a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial reporting standards.\u00a0 The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable.\u00a0 The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public and private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
\n "}]},{"name":"rpt:f-363","factDimensions":{"xbrl:concept":"plnhf:ScheduleOfSubsidiariesTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \nSubsidiaries as at December 31, 2022 | \u00a0 | Jurisdiction of Incorporation | \u00a0 | Ownership Interest 2022 | \u00a0 | Ownership Interest 2021 | Nature of Business | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
MM Development Company, Inc. (\"MMDC\") | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Nevada license holding company; vertically integrated cannabis operations | ||
BLC Management Company LLC | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Management/holding company | ||
LBC CBD LLC (\"LBC\") | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | CBD retail sales and marketing | ||
Newtonian Principles Inc. | \u00a0 | California, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | California license holding company; cannabis retail sales | ||
Crossgate Capital U.S. Holdings Corp. | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 0 | % | Holding company | ||
Next Green Wave, LLC | \u00a0 | California, USA | \u00a0 | 100 | % | \u00a0 | 0 | % | California license holding company; cannabis cultivation and processing | ||
Planet 13 Illinois, LLC | \u00a0 | Illinois, USA | \u00a0 | 49 | % | \u00a0 | 49 | % | Illinois license holding company | ||
BLC NV Food, LLC | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Holding company for By The Slice LLC | ||
By The Slice, LLC | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Subsidiary of BLC NV Food, LLC; restaurant and retail operations | ||
Planet 13 Chicago, LLC | \u00a0 | Illinois, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Holding company | ||
Planet 13 Florida, Inc. | \u00a0 | Florida, USA | \u00a0 | 100 | % | \u00a0 | 100 | % | Florida license holding company | ||
Club One Three, LLC | \u00a0 | Nevada, USA | \u00a0 | 100 | % | \u00a0 | N/A | Inactive |
| 3. Significant accounting policies |
\u00a0
\n(a) Cash
\n\u00a0
\nCash is comprised of cash deposits in financial institutions plus cash held at its retail locations and other deposits that are readily convertible to cash.
\n\u00a0
\n(b) Inventory
\n\u00a0
\nInventory is comprised of raw materials, finished goods and work-in-progress. Cost includes expenditures directly related to the cultivation and manufacturing process as well as suitable portions or related production overheads, based on normal operating capacity. Cannabis: Inventory cost includes pre-harvest, post-harvest and shipment and fulfillment, as well as related accessories. Pre-harvest costs include labor and direct materials to grow cannabis, which includes water, electricity, nutrients, integrated pest management, growing supplies and allocated overhead. Post-harvest costs include costs associated with drying, trimming, blending, extraction, purification, quality testing and allocated overhead. Shipment and fulfillment costs include the costs of packaging, labeling, courier services and allocated overhead. Inventory is stated at the lower of cost or net realizable value, determined using weighted average cost. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment of inventory and records write-downs for excess and obsolete inventories based on the Company\u2019s estimated forecast of product demand, production requirements, market conditions, regulatory environment, and spoilage. Actual inventory losses may differ from management\u2019s estimates and such differences could be material to the Company\u2019s balance sheets, statements of net loss and comprehensive loss and statements of cash flows.
\n\u00a0
\n \n \n(c) Property and equipment
\n\u00a0
\nProperty and equipment are stated at cost, net of accumulated depreciation and impairment losses, if any. Additions and improvements that materially increase the life of the assets are capitalized while maintenance and repairs are expensed as incurred. Significant expenditures, which extend the useful lives of assets or increase productivity are capitalized. When significant parts of one of our property and equipment have different useful lives, they are accounted for as separate items or components of property and equipment. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized in the consolidated statements of operations.
\n\u00a0
\nDepreciation is calculated on a straight-line basis over the following expected useful lives:
\n\u00a0
\n \nLand | \u00a0 | \u00a0 | Not depreciated | \u00a0 |
Land improvements (in years) | \u00a0 | 5 | ||
Building (in years) | \u00a0 | 5 \u2013 40 | ||
Equipment (in years) | \u00a0 | 5 \u2013 7 | ||
Leasehold improvements | \u00a0 | \u00a0 | Shorter of estimated useful life or remaining lease term | \u00a0 |
Construction in progress | \u00a0 | \u00a0 | Not depreciated | \u00a0 |
\u00a0
\nAn assets residual value, useful life and depreciation method are reviewed at each reporting period with the effect of any changes in estimate accounted for on a prospective basis.\u00a0 Depreciation of property and equipment commences when the asset is available for use.
\n\u00a0
\nConstruction in progress includes construction progress payments, deposits, engineering costs and other costs directly related to the construction of the facilities.\u00a0 Expenditures are capitalized during the construction period and construction in progress in transferred to the relevant class of property and equipment when the assets are available for use, at which point in time the depreciation of the asset commences.
\n\u00a0
\nProperty and equipment acquired in a business combination is depreciated over the remaining useful life of the asset.
\n\u00a0
\n(d) Intangible assets
\n\u00a0
\nIntangible assets include licenses acquired as part of business combinations, asset acquisitions and other business transactions. The Company records intangible assets at cost, net of accumulated amortization and accumulated impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value on the acquisition date.
\n\u00a0
\nWhen there is no foreseeable limit on the period of time over which an intangible asset is expected to contribute to the cash flows of the Company, an intangible asset is determined to have an indefinite life.\u00a0 Indefinite life intangible assets are tested for impairment annually, or more frequently when events or circumstances indicate that impairment may have occurred.\u00a0 As part of the impairment evaluation, the Company may elect to perform an assessment of qualitative factors.\u00a0 If this qualitative assessment indicates that it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value, a quantitative impairment test is required to compare the fair value of the asset to its carrying value.\u00a0 If the carrying value of an individual indefinite-lived intangible asset exceeds its fair value, such individual indefinite-life intangible asset is impaired by the amount of the excess.
\n\u00a0
\nThe estimated useful life and amortization method are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis. The Company's intangible assets\u00a0have an indefinite life.
\n\u00a0
\n \n \n(e) Goodwill impairment test
\n\u00a0
\nIn accordance with the accounting standards, an entity has the option first to assess qualitative factors to determine whether events and circumstances indicate that it is more likely than not that goodwill or an indefinite-lived intangible asset is impaired. If after such assessment an entity concludes that the asset is not impaired, then the entity is not required to take further action. However, if an entity concludes otherwise, then it is required to determine the fair value of the asset using a quantitative impairment test, and if impaired, the associated assets must be written down to fair value. The quantitative impairment test for goodwill compares the fair value of a reporting unit with the carrying value of its net assets, including goodwill. If the fair value of the reporting unit is less than the carrying value of the reporting unit, an impairment charge would be recorded to the Company\u2019s operations, for the amount in which the carrying amount exceeds the reporting unit\u2019s fair value. The estimate of fair value requires the use of significant unobservable inputs, representative of a Level 3 fair value measurement. The Company determines fair values for each reporting unit using the income approach, when available and appropriate, the market approach, or a combination of both. The income approach involves forecasting projected financial information (such as revenue growth rates, profit margins, tax rates, working capital and capital expenditures) and selecting a discount rate that reflects the risk inherent in estimated future cash flows. Under the market approach, the fair value is based on observed market data. If multiple valuation methodologies are used, the results are weighted appropriately.
\n\u00a0
\nThe Company performs an annual assessment of its goodwill as of December 31, or more frequently, to determine if any events or circumstances exist, such as an adverse change in business climate or a decline in overall industry demand, that would indicate that it would more likely than not reduce the fair value of a reporting unit below its carrying amount, including goodwill.
\n\u00a0
\n(f)\u00a0Impairment of long-lived assets
\n\u00a0
\nThe Company reviews long-lived assets, including property and equipment and definite life intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable.\u00a0 In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (\u201casset group\u201d).\u00a0 When indicators of potential impairment are present the Company prepares a projected undiscounted cash flow analysis for the respective asset or asset group.\u00a0 If the sum of the undiscounted cash flows is less than the carrying value of the asset or asset group, an impairment loss is recognized equal to the excess of the carrying value over the fair value, if any.\u00a0 Fair value can be determined using a market approach, income approach or cost approach.\u00a0 The reversal of impairment losses is prohibited.
\n\u00a0
\n(g)\u00a0Share-based compensation
\n\u00a0
\nThe Company has an equity incentive plan which includes issuances of stock options and restricted share units (\u201cRSUs\u201d).\u00a0 From time to time, the Company also enters into share-based compensation agreements with non-employees.\u00a0 The accounting for these arrangements typically aligns with those of employees.
\n\u00a0
\nThe Company measures and recognizes compensation expense for stock options and RSUs to employees and non-employees on a straight-line basis over the vesting period based on their grant date fair values. Prior to the adoption of ASU 2018 07 on January 1, 2019, the fair value of stock options to non-employees were re-measured at each reporting date until one of either of the counterparty\u2019s commitment to perform is established or until the performance is complete. After adopting ASU 2018-07 which made amendments to ASC Topic 718, Stock Compensation, an acquirer measures share-based compensation to non-employees in exchange for goods and services in the same manner as share-based payments to employees, using a fair-value based approach measured at the grant date.\u00a0 This guidance is followed if the acquirer considers the assets and goods to be used or consumed in its own operation.\u00a0 If not, the Company has elected to account for the equity interests issued in accordance with ASC 805, Business Combinations, based on the fair value of the equity interests issued.
\n\u00a0
\nThe Company estimates the fair value of stock options on the date of grant using the Black-Scholes option pricing model. Determining the estimated fair value of at the grant date requires judgment in determining the appropriate valuation model and assumptions, including the fair value of shares on the grant date, risk-free rate, volatility rate, annual dividend yield and the expected term. The volatility rate is based on historical volatilities of public companies operating in a similar industry to the Company, as well as the Company\u2019s historical volatility. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate is based on the Government of Canada Bond yields on the date of the option grant with a remaining term equal to the expected life of the options. The Company estimates the fair value of RSUs to be the closing market price of the Company\u2019s stock on the grant date.
\n\u00a0
\n \n \nFor stock options granted, the Company uses the fair value of common stock at the date of grant. The Company does not estimate forfeiture rates when calculating compensation expense for stock options or RSUs. The Company records forfeitures as they occur.
\n\u00a0
\nFully vested, non-forfeitable equity instruments issued to parties other than employees are measured on the date they are issued where there is no specific performance required by the grantee to retain those equity instruments. Share-based compensation transactions with non-employees are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. Where fully vested, non-forfeitable equity instruments are granted to parties other than employees in exchange for notes or financing receivable, the note or receivable is presented in additional paid-in capital on the balance sheets.\u00a0
\n\u00a0
\n(h)\u00a0Warrant liability
\n\u00a0
\nWarrants are accounted for in accordance with the authoritative accounting guidance in ASC Topic 815, Derivatives and Hedging \u2013 Contracts in Entity\u2019s Own Equity (\u201cASC 815\u201d), as either derivative liabilities or as equity instruments depending on the specific terms of the warrant agreements.\u00a0 Liability-classified instruments are recorded at fair value at each reporting period with any change in fair value recognized as a component of change in fair value of derivative liabilities in the consolidated statements of operations and comprehensive loss.\u00a0 Transaction costs allocated to warrants that are presented as a liability are expensed immediately within other income (expense) in the consolidated statement of operations and comprehensive loss.\u00a0 Refer to paragraph (n) below as well as Note 11 for a discussion on the change in the warrant liability value.
\n\u00a0
\n(i)\u00a0Revenue recognition
\n\u00a0
\nThe Company earns revenue primarily from the sale of cannabis to eligible retail customers at the Company-owned dispensaries, in addition to the wholesale of cannabis products to dispensary locations.\u00a0 The Company recognizes revenue to depict the transfer of promised goods or services to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for the performance obligations.
\n\u00a0
\nIn order to recognize revenue, the Company applies the following five (5) steps:
\n\u00a0
\n| 1) | Identify the contract with the customer |
| 2) | Identify the performance obligation(s) |
| 3) | Determine the transaction price |
| 4) | Allocate the transaction price to the performance obligation(s) |
| 5) | Recognize revenue when/as performance obligation(s) are satisfied |
\u00a0
\nRevenue is recognized when control of the promised goods or services, through performance obligations by the Company, is transferred to the customer in an amount that reflects the consideration it expects to be entitled to in exchange for the performance obligations. More specifically, wholesale revenues are recognized upon delivery and acceptance by wholesale customers. Retail revenues are recognized at the point of sale. Discounts are recorded at the time of revenue recognition.\u00a0 Returns were not material during the years ended December 31, 2022, and 2021, but are recognized when the customer is refunded. Revenues are presented net of discounts and returns. At one of the Company\u2019s entities, sales are made on consignment and revenue is not recognized until title passes upon delivery of the product by that distributor to their dispensary customers. Revenue on these sales is recognized upon shipment to the customer.
\n\u00a0
\nSales taxes collected from customers are remitted to the appropriate taxing jurisdictions and are excluded from sales revenue as the Company considers itself a pass-through conduit for collecting and remitting sales taxes. Excise duties that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer are included in revenue. Freight revenues on all product sales, when applicable, are also recognized, on a consistent manner, at a point in time. The term between invoicing and when payment is due is not significant and the period between when the entity transfers the promised good or service to the customer and when the customer pays for that good or service is one year or less.
\n\u00a0
\n \n \nThe following table represents the Company\u2019s disaggregated revenue by sales channel:
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, | \u00a0 | \u00a0 | December 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2022 | \u00a0 | \u00a0 | 2021 | \u00a0 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Retail | \u00a0 | $ | 90,363,557 | \u00a0 | \u00a0 | $ | 114,792,191 | \u00a0 |
| Wholesale | \u00a0 | \u00a0 | 14,210,820 | \u00a0 | \u00a0 | \u00a0 | 4,701,244 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Net revenues | \u00a0 | $ | 104,574,377 | \u00a0 | \u00a0 | $ | 119,493,435 | \u00a0 |
\u00a0
\nLoyalty Points Reward Programs
\n\u00a0
\nIn certain of its markets, the Company offers a loyalty reward program to its dispensary customers that allows its customers to earn discounts on future purchases. \u00a0Loyalty points are earned when a qualifying purchase is made.\u00a0 When a customer attains a certain number of points, the customer can redeem the credits on future in-store purchases.\u00a0 Loyalty points do not have an expiration date.
\n\u00a0
\nA portion of the revenue generated in a sale is allocated to the loyalty points earned.\u00a0 The amount allocated to the points earned is deferred until the loyalty points are redeemed.
\n\u00a0
\nDeferred Income
\n\u00a0
\nDeferred income represents cash payments received in advance of the Company\u2019s transfer of control of products or services to its customers and generally consists of unearned revenue from the Company\u2019s loyalty programs.\u00a0 The Company\u2019s deferred income balances were $1,047,781\u00a0and $759,060 as of December 31, 2022 and 2021, respectively, and were recorded within accrued expenses in the consolidated balance sheets.\u00a0 During the years ended December 31, 2022 and 2021, the Company recognized $1,082,994 and $1,136,135, respectively, of net revenues from amounts recorded as deferred income.\u00a0 The deferred income balance as of December 31, 2022 is expected to be recognized as revenue within the next months.
\n\u00a0
\nThe Company determined that no provision for returns or refunds was necessary as at December 31, 2022 or 2021.\u00a0
\n\u00a0
\n(j)\u00a0 Cost of Sales
\n\u00a0
\nCost of sales represents costs directly related to manufacturing and distribution of the Company\u2019s products. Primary costs include raw materials, packaging, direct labor, overhead, shipping and handling, the depreciation of certain property, plant and equipment, and tariffs. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes. Cost of sales also includes inventory valuation adjustments. The Company recognizes the cost of sales as the associated revenues are recognized.
\n\u00a0
\n(k) Leases
\n\u00a0
\nThe Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (\u201cROU\u201d) assets and right-of-use liabilities (current and non-current) in the balance sheets. Finance lease ROU assets and ROU liabilities (current and non-current), if any, are included finance lease in the balance sheets.
\n\u00a0
\nROU assets represent the Company\u2019s right to use an underlying asset for the lease term and lease liabilities represent the Company\u2019s obligation to make lease payments arising from the lease. ROU assets are classified as a finance lease or an operating lease. A finance lease is a lease in which 1) ownership of the property transfers to the lessee by the end of the lease term; 2) the lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise; 3) the lease is for a major part of the remaining economic life of the underlying asset; 4) The present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already included in the lease payments equals or exceeds substantially all of the fair value; or 5) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. The Company classifies a lease as an operating lease when it does not meet any one of these criteria.
\n\u00a0
\n \n \nROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company\u2019s leases do not provide an implicit rate, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. The ROU assets also include any lease payments made and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.
\n\u00a0
\nFor finance leases, lease expenses are the sum of interest on the lease obligations and amortization of the ROU assets, resulting in a front-loaded expense pattern. ROU assets are amortized based on the lesser of the lease term and the useful life of the leased asset according to the property and equipment accounting policy. If ownership of the ROU assets transfers to the Company at the end of the lease term or if the Company is reasonably certain to exercise a purchase option, amortization is calculated using the estimated useful life of the leased asset, according to the property and equipment accounting policy. For operating leases, the lease expenses are generally recognized on a straight-line basis over the lease term and recorded to lease expenses or, in the case of leases directly related to the cultivation of cannabis, in cost of goods sold in the statements of operations and comprehensive loss.
\n\u00a0
\nThe Company has elected to apply the practical expedient, for each class of underlying asset, except real estate leases, to not separate non-lease components from the associated lease components of the lessee\u2019s contract and account for both components as a single lease component.
\n\u00a0
\nThe Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less that do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise. Short-term leases include real estate and vehicles and are not significant in comparison to the Company\u2019s overall lease portfolio. The Company continues to recognize the lease payments associated with these leases as expenses on a straight-line basis over the lease term.
\n\u00a0
\n(l) Income taxes
\n\u00a0
\nIncome taxes are comprised of current and deferred taxes. These taxes are accounted for using the asset and liability method of accounting for income taxes under ASC 740 Income Taxes. Deferred tax is recognized on the difference between the carrying amount of an asset or a liability, as reflected in the consolidated financial statements, and the corresponding tax base used in the computation of income for tax purposes (\"temporary difference\") and measured using the enacted tax rates and laws as at the balance sheet date that are expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. Management assesses the likelihood that a deferred tax asset will be realized, and a valuation allowance is provided to the extent that it is more likely than not that all or a portion of a deferred tax asset will not be realized. If it is subsequently determined that the Company will be able to realize deferred tax assets in excess of the net recorded amount, then the valuation allowance will be adjusted accordingly in the period in which this determination is made.\u00a0Current tax is recognized in connection with income for tax purposes, unrecognized tax benefits and the recovery of tax paid in a prior period and measured using the enacted tax rates and laws applicable to the taxation period during which the income for tax purposes arose. An unrecognized tax benefit may arise in connection with a period that has not yet been reviewed by the relevant tax authority. A change in the recognition or measurement of an unrecognized tax benefit is reflected in the period during which the change occurs.
\n\u00a0
\nThe Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes.
\n\u00a0
\nInterest and penalties in respect of income taxes are not recognized in the consolidated statement of operations and comprehensive loss as a component of income taxes but as a component of interest expense.
\n\u00a0
\nAs the Company operates in the cannabis industry, it is subject to the limits of U.S. Internal Revenue Code (\u201cIRC\u201d) Section 280E (\u201cSection 280E\u201d) under which the Company is only allowed to deduct expenses directly related to the cost of producing the products or cost of production.
\n\u00a0
\n(m) Sales and marketing expenses
\n\u00a0
\nThe Company expenses sales and marketing costs when incurred. Sales and marketing expense was $3,504,309 for the year ended December 31, 2022 (2021 - $5,969,792).
\n\u00a0
\n \n \n(n) Fair value measurements
\n\u00a0
\nFair value is the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. Fair value measurement for invested assets are categorized into levels within a fair value hierarchy based on the nature of the valuation inputs (Levels 1, 2 or 3). The three levels are defined based on the observability of significant inputs to the measurement, as follows:
\n\u00a0
\n| \u00a0 | \u25cf | Level 1: quoted prices (unadjusted) in active markets for identical or liabilities; |
| \u00a0 | \u25cf | Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and |
| \u00a0 | \u25cf | Level 3: one or more significant inputs used in a valuation technique are unobservable in determining fair values of the asset or liability |
\u00a0
\nDetermination of fair value and the resulting hierarchy requires the use of observable market data whenever available. The classification of an asset or liability in the hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The carrying value of the Company\u2019s cash, accounts receivable, deposits, accounts payable, accrued expenses, and notes payable approximate their fair value due to their short-term nature. Warrant liability is measured based on level 1 inputs (Note 11).
\n\u00a0
\nThe\u00a0Company's\u00a0prepaid and other current assets, long lived assets, including property and equipment, intangible assets and goodwill are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized.
\n\u00a0
\n(o) Loss\u00a0per share
\n\u00a0
\nBasic net loss per share is computed by dividing reported net loss by the weighted average number of common shares outstanding for the reported period. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock of the Company during the reporting period. Diluted earnings per share is computed by dividing net loss by the sum of the weighted average number of common shares and the number of potentially dilutive common share equivalents outstanding during the period. Potential dilutive common share equivalents consist of the incremental common shares issuable upon the exercise of vested share options. When the Company is incurring losses, basic and diluted loss per share are the same since including the exercise of outstanding options and warrants in the diluted loss per share calculation would be antidilutive.\u00a0
\n\u00a0
\n(p) Operating segments
\n\u00a0
\nOperating segments are components of the Company that engage in business activities which generate revenues and incur expenses (including intercompany revenues and expenses related to transactions conducted with other components of the Company). The operations of an operating segment are distinct, and the operating results are regularly reviewed by the chief operating decision maker (\u201cCODM\u201d) for the purposes of resource allocation decisions and assessing its performance. The Company's Co-Chief Executive Officers are the Company's CODM.
\n\u00a0
\nThe Company determined that each of its locations represents an operating segment. These operating segments have been aggregated into a single reportable segment as the Company\u00a0operates\u00a0as a vertically integrated cannabis company with dispensary, cultivation, production and distribution operations in the state of Nevada and dispensary, cultivation and distribution\u00a0operations in\u00a0the state of California.
\n\u00a0
\nAs at December 31, 2022 and 2021, all the Company\u2019s non-current assets were located in the United States and 100% of the Company\u2019s revenue was generated in the United States.
\n\u00a0
\n \n \n(q)\u00a0 Critical accounting estimates and judgements
\n\u00a0
\nThe preparation of consolidated financial statements in conformity with GAAP requires the Company\u2019s management to make judgements, estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements. Although these estimates are based on management\u2019s best knowledge of the amount, event or actions, actual results may differ from those estimates. Estimates and judgements are continuously evaluated and are based on management\u2019s experience and other factors, including expectations of future events that are believed to be reasonable.\u00a0
\n\u00a0
\nRevisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.
\n\u00a0
\nFinancial statement areas that require significant judgments are as follows:
\n\u00a0
\nEstimated useful lives and depreciation of property and equipment, right-of-use assets
\n\u00a0
\nDepreciation and amortization of property and equipment, right-of-use assets and intangible assets are dependent upon estimates of useful lives, which are determined through the exercise of judgment. Impairment of definite long-lived assets is influenced by judgment in defining a an asset group\u00a0and determining the indicators of impairment, and estimates used to measure impairment losses. Refer to Notes 6,\u00a07 and 8 for further information.
\n\u00a0
\nLeases
\n\u00a0
\nThe Company applies judgement in determining whether a contract contains a lease and if a lease is classified as an operating lease or a finance lease.
\n\u00a0
\nThe Company determines the lease term as the non-cancellable term of the lease, which may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The lease term is used in determining classification between operating lease and finance lease, calculating the lease liability and determining the incremental borrowing rate.\u00a0 The Company has several lease contracts that include extension and termination options. The Company applies judgement in evaluating whether it is reasonably certain to exercise the option to renew or terminate the lease. That is, it considers all relevant factors that create an economic incentive for it to exercise either the renewal or termination. After the commencement date of the lease, the Company reassesses the lease term if there is a significant event or change in circumstances that is within its control and affects its ability to exercise or not to exercise the option to renew or to terminate (e.g., construction of significant leasehold improvements or significant customization to the leased asset).
\n\u00a0
\nThe Company is required to discount lease payments using the rate implicit in the lease if that rate is readily available. If that rate cannot be readily determined, the lessee is required to use its incremental borrowing rate. The Company generally uses the incremental borrowing rate when initially recording real estate leases.\u00a0 Information from the lessor regarding the fair value of underlying assets and initial direct costs incurred by the lessor related to the leased assets is not available. The Company determines the incremental borrowing rate as the interest rate the Company would pay to borrow over a similar term the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.
\n\u00a0
\nDefinition of a business
\n\u00a0
\nDetermination of what constitutes a business for purposes of acquisition accounting requires significant judgement.\u00a0 ASC 805 notes that if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, the set is not considered a business. However, the exact quantitative threshold is not explicitly defined. During the year ended December 31, 2022, the Company completed one acquisition, further described in Note 7.
\n\u00a0
\nAsset Impairment
\n\u00a0
\nAsset impairment tests require the allocation of assets to asset groups, where appropriate, which requires significant judgment and interpretation with respect to the integration between the assets and shared resources. Asset impairment tests require the determination of whether there is an indication of impairment. The assessment of whether an indication of impairment exists is performed at the end of each reporting period and requires the application of judgment, historical experience, and external and internal sources of information.
\n\u00a0
\n \n \nDeferred tax assets and uncertain tax positions
\n\u00a0
\nThe Company recognizes deferred tax assets and liabilities based on the differences between the consolidated financial statement carrying amounts and the respective tax bases of its assets and liabilities. The Company measures deferred tax assets and liabilities using current enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. The Company routinely evaluates the likelihood of realizing the benefit of its deferred tax assets and may record a valuation allowance if, based on all available evidence, it determines that some portion of the tax benefit will not be realized.
\n\u00a0
\nIn evaluating the ability to recover deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax-planning strategies and results of operations. In projecting future taxable income, the Company considers historical results and incorporates assumptions about the amount of future pretax operating income adjusted for items that do not have tax consequences. The Company\u2019s assumptions regarding future taxable income are consistent with the plans and estimates that are used to manage its underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income (loss). The income tax expense, deferred tax assets and liabilities and liabilities for unrecognized tax benefits reflect the Company\u2019s best assessment of estimated current and future taxes to be paid. Deferred tax asset valuation allowances and liabilities for unrecognized tax benefits require significant judgment regarding applicable statutes and their related interpretation, the status of various income tax audits and the Company\u2019s particular facts and circumstances. Although the Company believes that the judgments and estimates discussed herein are reasonable, actual results, including forecasted COVID-19 business recovery, could differ, and the Company may be exposed to losses or gains that could be material. To the extent the Company prevails in matters for which a liability has been established or is required to pay amounts in excess of the established liability, the effective income tax rate in a given financial statement period could be materially affected.
\n\u00a0
\nKey estimates in these consolidated financial statements include:
\n\u00a0
\nShare-based compensation
\n\u00a0
\nThe Company uses the Black-Scholes valuation model to determine the fair value of options and warrants granted to employees and non-employees under share-based payment arrangements, where appropriate. In estimating fair value, management is required to make certain assumptions and estimates such as the expected term of the instrument, volatility of the Company\u2019s future share price, risk free rates, future dividend yields and estimated forfeitures at the initial grant date, by reference to the underlying terms of the instrument, and the Company\u2019s experience with similar instruments. Changes in assumptions used to estimate fair value could result in materially different results. Refer to Note 12 for further information.
\n\u00a0
\nValuation of inventory
\n\u00a0
\nInventory is comprised of raw materials, work-in-progress and finished goods. Cannabis and hemp costs include expenditures directly related to the manufacturing process as well as suitable portions of related production overheads, based on normal operating capacity. At the end of each reporting period, the Company performs an assessment of inventory and records inventory valuation adjustments for excess and obsolete inventories based on the estimated forecast of product demand, production requirements, market conditions, regulatory environment, and spoilage. A reserve is estimated to ensure the inventory balance at the end of the year reflects the estimates of product the Company expects to sell in the next year. Changes in the regulatory structure, lack of retail distribution locations or lack of consumer demand could result in future inventory reserves.
\n\u00a0
\nImpairment of indefinite life intangible assets and goodwill
\n\u00a0
\nThe assessment of whether an indication of impairment exists is performed at the end of each reporting period and requires the application of judgment, historical experience, and external and internal sources of information. The Company makes estimates in determining the future cash flows and discount rates in the quantitative impairment test to compare the fair value to the carrying value.
\n\u00a0
\n \n \n(r) Accounting standards issued but not yet effective
\n\u00a0
\nBusiness Combinations
\n\u00a0
\nIn October 2021, the FASB issued ASU 2021-08, Accounting for Contract Assets and Contact Liabilities from Contracts with Customers (\u201cASU 2021-08\u201d) (\u201cASC 805\u201d). ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities from acquired contracts using the revenue recognition guidance under ASC 606 in order to align the recognition of a contract liability with the definition of performance obligation. This approach differences from the current requirement to measure contract assets and contract liabilities acquired in a business combination at fair value. ASU 2021-08 is effective for financial statements of non-public business entities issued for fiscal years beginning after December 15, 2023 and early adoption is permitted. The Company is currently evaluating the effect of adopting this ASU.
\n\u00a0
\n(s) Sale-leaseback transactions
\n\u00a0
\nFrom time to time, the Company may enter into sale-leaseback transactions to finance certain property acquisitions and capital expenditures, pursuant to which the Company sells the property to a third party and agrees to lease the property back for a certain period of time. To determine whether the transfer of the property should be accounted for as a sale, the Company evaluates whether it has transferred control to the third party in accordance with the revenue recognition guidance set forth in ASC 606.
\n\u00a0
\nIf the transfer of the asset is deemed to be a sale at market terms, the Company recognizes the transaction price for the sale based on the cash proceeds received, derecognizes the carrying amount of the underlying asset and recognizes a gain or loss in the consolidated statements of operations and comprehensive loss for any difference between the carrying value of the asset and the transaction price. The Company then accounts for the leaseback in accordance with its lease accounting policy.
\n\u00a0
\nIf the transfer of the asset is determined not to be a sale at market terms, the Company accounts for the transaction as a financing arrangement, and accordingly no asset sale is recognized. The Company retains the historical costs of the property and the related accumulated depreciation on its books and continues to depreciate the property over the lesser of its remaining useful life or its initial lease term. The asset is presented within property and equipment, net on the consolidated balance sheets. All proceeds from these transactions are accounted for as finance obligations and presented as non-current obligations on the consolidated balance sheets. A portion of the lease payments is recognized as a reduction of the financing obligation and a portion is recognized as interest expense based on an imputed interest rate.
\n "}]},{"name":"rpt:f-388","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(a) Cash
\n\u00a0
\nCash is comprised of cash deposits in financial institutions plus cash held at its retail locations and other deposits that are readily convertible to cash.
"}]},{"name":"rpt:f-389","factDimensions":{"xbrl:concept":"us-gaap:InventoryPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(b) Inventory
\n\u00a0
\nInventory is comprised of raw materials, finished goods and work-in-progress. Cost includes expenditures directly related to the cultivation and manufacturing process as well as suitable portions or related production overheads, based on normal operating capacity. Cannabis: Inventory cost includes pre-harvest, post-harvest and shipment and fulfillment, as well as related accessories. Pre-harvest costs include labor and direct materials to grow cannabis, which includes water, electricity, nutrients, integrated pest management, growing supplies and allocated overhead. Post-harvest costs include costs associated with drying, trimming, blending, extraction, purification, quality testing and allocated overhead. Shipment and fulfillment costs include the costs of packaging, labeling, courier services and allocated overhead. Inventory is stated at the lower of cost or net realizable value, determined using weighted average cost. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment of inventory and records write-downs for excess and obsolete inventories based on the Company\u2019s estimated forecast of product demand, production requirements, market conditions, regulatory environment, and spoilage. Actual inventory losses may differ from management\u2019s estimates and such differences could be material to the Company\u2019s balance sheets, statements of net loss and comprehensive loss and statements of cash flows.
"}]},{"name":"rpt:f-390","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(c) Property and equipment
\n\u00a0
\nProperty and equipment are stated at cost, net of accumulated depreciation and impairment losses, if any. Additions and improvements that materially increase the life of the assets are capitalized while maintenance and repairs are expensed as incurred. Significant expenditures, which extend the useful lives of assets or increase productivity are capitalized. When significant parts of one of our property and equipment have different useful lives, they are accounted for as separate items or components of property and equipment. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized in the consolidated statements of operations.
\n\u00a0
\nDepreciation is calculated on a straight-line basis over the following expected useful lives:
\n\u00a0
\n \nLand | \u00a0 | \u00a0 | Not depreciated | \u00a0 |
Land improvements (in years) | \u00a0 | 5 | ||
Building (in years) | \u00a0 | 5 \u2013 40 | ||
Equipment (in years) | \u00a0 | 5 \u2013 7 | ||
Leasehold improvements | \u00a0 | \u00a0 | Shorter of estimated useful life or remaining lease term | \u00a0 |
Construction in progress | \u00a0 | \u00a0 | Not depreciated | \u00a0 |
\u00a0
\nAn assets residual value, useful life and depreciation method are reviewed at each reporting period with the effect of any changes in estimate accounted for on a prospective basis.\u00a0 Depreciation of property and equipment commences when the asset is available for use.
\n\u00a0
\nConstruction in progress includes construction progress payments, deposits, engineering costs and other costs directly related to the construction of the facilities.\u00a0 Expenditures are capitalized during the construction period and construction in progress in transferred to the relevant class of property and equipment when the assets are available for use, at which point in time the depreciation of the asset commences.
\n\u00a0
\nProperty and equipment acquired in a business combination is depreciated over the remaining useful life of the asset.
"}]},{"name":"rpt:f-391","factDimensions":{"xbrl:concept":"plnhf:ScheduleOfExpectedLivesOfPropertyAndEquipmentTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \nLand | \u00a0 | \u00a0 | Not depreciated | \u00a0 |
Land improvements (in years) | \u00a0 | 5 | ||
Building (in years) | \u00a0 | 5 \u2013 40 | ||
Equipment (in years) | \u00a0 | 5 \u2013 7 | ||
Leasehold improvements | \u00a0 | \u00a0 | Shorter of estimated useful life or remaining lease term | \u00a0 |
Construction in progress | \u00a0 | \u00a0 | Not depreciated | \u00a0 |
(d) Intangible assets
\n\u00a0
\nIntangible assets include licenses acquired as part of business combinations, asset acquisitions and other business transactions. The Company records intangible assets at cost, net of accumulated amortization and accumulated impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value on the acquisition date.
\n\u00a0
\nWhen there is no foreseeable limit on the period of time over which an intangible asset is expected to contribute to the cash flows of the Company, an intangible asset is determined to have an indefinite life.\u00a0 Indefinite life intangible assets are tested for impairment annually, or more frequently when events or circumstances indicate that impairment may have occurred.\u00a0 As part of the impairment evaluation, the Company may elect to perform an assessment of qualitative factors.\u00a0 If this qualitative assessment indicates that it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value, a quantitative impairment test is required to compare the fair value of the asset to its carrying value.\u00a0 If the carrying value of an individual indefinite-lived intangible asset exceeds its fair value, such individual indefinite-life intangible asset is impaired by the amount of the excess.
\n\u00a0
\nThe estimated useful life and amortization method are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis. The Company's intangible assets\u00a0have an indefinite life.
"}]},{"name":"rpt:f-398","factDimensions":{"xbrl:concept":"us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(f)\u00a0Impairment of long-lived assets
\n\u00a0
\nThe Company reviews long-lived assets, including property and equipment and definite life intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable.\u00a0 In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (\u201casset group\u201d).\u00a0 When indicators of potential impairment are present the Company prepares a projected undiscounted cash flow analysis for the respective asset or asset group.\u00a0 If the sum of the undiscounted cash flows is less than the carrying value of the asset or asset group, an impairment loss is recognized equal to the excess of the carrying value over the fair value, if any.\u00a0 Fair value can be determined using a market approach, income approach or cost approach.\u00a0 The reversal of impairment losses is prohibited.
"}]},{"name":"rpt:f-399","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n(g)\u00a0Share-based compensation
\n\u00a0
\nThe Company has an equity incentive plan which includes issuances of stock options and restricted share units (\u201cRSUs\u201d).\u00a0 From time to time, the Company also enters into share-based compensation agreements with non-employees.\u00a0 The accounting for these arrangements typically aligns with those of employees.
\n\u00a0
\nThe Company measures and recognizes compensation expense for stock options and RSUs to employees and non-employees on a straight-line basis over the vesting period based on their grant date fair values. Prior to the adoption of ASU 2018 07 on January 1, 2019, the fair value of stock options to non-employees were re-measured at each reporting date until one of either of the counterparty\u2019s commitment to perform is established or until the performance is complete. After adopting ASU 2018-07 which made amendments to ASC Topic 718, Stock Compensation, an acquirer measures share-based compensation to non-employees in exchange for goods and services in the same manner as share-based payments to employees, using a fair-value based approach measured at the grant date.\u00a0 This guidance is followed if the acquirer considers the assets and goods to be used or consumed in its own operation.\u00a0 If not, the Company has elected to account for the equity interests issued in accordance with ASC 805, Business Combinations, based on the fair value of the equity interests issued.
\n\u00a0
\nThe Company estimates the fair value of stock options on the date of grant using the Black-Scholes option pricing model. Determining the estimated fair value of at the grant date requires judgment in determining the appropriate valuation model and assumptions, including the fair value of shares on the grant date, risk-free rate, volatility rate, annual dividend yield and the expected term. The volatility rate is based on historical volatilities of public companies operating in a similar industry to the Company, as well as the Company\u2019s historical volatility. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate is based on the Government of Canada Bond yields on the date of the option grant with a remaining term equal to the expected life of the options. The Company estimates the fair value of RSUs to be the closing market price of the Company\u2019s stock on the grant date.
\n\u00a0
\n \n \nFor stock options granted, the Company uses the fair value of common stock at the date of grant. The Company does not estimate forfeiture rates when calculating compensation expense for stock options or RSUs. The Company records forfeitures as they occur.
\n\u00a0
\nFully vested, non-forfeitable equity instruments issued to parties other than employees are measured on the date they are issued where there is no specific performance required by the grantee to retain those equity instruments. Share-based compensation transactions with non-employees are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. Where fully vested, non-forfeitable equity instruments are granted to parties other than employees in exchange for notes or financing receivable, the note or receivable is presented in additional paid-in capital on the balance sheets.\u00a0
"}]},{"name":"rpt:f-400","factDimensions":{"xbrl:concept":"plnhf:WarrantLiabilityPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(h)\u00a0Warrant liability
\n\u00a0
\nWarrants are accounted for in accordance with the authoritative accounting guidance in ASC Topic 815, Derivatives and Hedging \u2013 Contracts in Entity\u2019s Own Equity (\u201cASC 815\u201d), as either derivative liabilities or as equity instruments depending on the specific terms of the warrant agreements.\u00a0 Liability-classified instruments are recorded at fair value at each reporting period with any change in fair value recognized as a component of change in fair value of derivative liabilities in the consolidated statements of operations and comprehensive loss.\u00a0 Transaction costs allocated to warrants that are presented as a liability are expensed immediately within other income (expense) in the consolidated statement of operations and comprehensive loss.\u00a0 Refer to paragraph (n) below as well as Note 11 for a discussion on the change in the warrant liability value.
"}]},{"name":"rpt:f-401","factDimensions":{"xbrl:concept":"us-gaap:RevenueRecognitionPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(i)\u00a0Revenue recognition
\n\u00a0
\nThe Company earns revenue primarily from the sale of cannabis to eligible retail customers at the Company-owned dispensaries, in addition to the wholesale of cannabis products to dispensary locations.\u00a0 The Company recognizes revenue to depict the transfer of promised goods or services to the customer in an amount that reflects the consideration to which the Company expects to be entitled in exchange for the performance obligations.
\n\u00a0
\nIn order to recognize revenue, the Company applies the following five (5) steps:
\n\u00a0
\n| 1) | Identify the contract with the customer |
| 2) | Identify the performance obligation(s) |
| 3) | Determine the transaction price |
| 4) | Allocate the transaction price to the performance obligation(s) |
| 5) | Recognize revenue when/as performance obligation(s) are satisfied |
\u00a0
\nRevenue is recognized when control of the promised goods or services, through performance obligations by the Company, is transferred to the customer in an amount that reflects the consideration it expects to be entitled to in exchange for the performance obligations. More specifically, wholesale revenues are recognized upon delivery and acceptance by wholesale customers. Retail revenues are recognized at the point of sale. Discounts are recorded at the time of revenue recognition.\u00a0 Returns were not material during the years ended December 31, 2022, and 2021, but are recognized when the customer is refunded. Revenues are presented net of discounts and returns. At one of the Company\u2019s entities, sales are made on consignment and revenue is not recognized until title passes upon delivery of the product by that distributor to their dispensary customers. Revenue on these sales is recognized upon shipment to the customer.
\n\u00a0
\nSales taxes collected from customers are remitted to the appropriate taxing jurisdictions and are excluded from sales revenue as the Company considers itself a pass-through conduit for collecting and remitting sales taxes. Excise duties that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer are included in revenue. Freight revenues on all product sales, when applicable, are also recognized, on a consistent manner, at a point in time. The term between invoicing and when payment is due is not significant and the period between when the entity transfers the promised good or service to the customer and when the customer pays for that good or service is one year or less.
\n\u00a0
\n \n \nThe following table represents the Company\u2019s disaggregated revenue by sales channel:
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, | \u00a0 | \u00a0 | December 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2022 | \u00a0 | \u00a0 | 2021 | \u00a0 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Retail | \u00a0 | $ | 90,363,557 | \u00a0 | \u00a0 | $ | 114,792,191 | \u00a0 |
| Wholesale | \u00a0 | \u00a0 | 14,210,820 | \u00a0 | \u00a0 | \u00a0 | 4,701,244 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Net revenues | \u00a0 | $ | 104,574,377 | \u00a0 | \u00a0 | $ | 119,493,435 | \u00a0 |
\u00a0
\nLoyalty Points Reward Programs
\n\u00a0
\nIn certain of its markets, the Company offers a loyalty reward program to its dispensary customers that allows its customers to earn discounts on future purchases. \u00a0Loyalty points are earned when a qualifying purchase is made.\u00a0 When a customer attains a certain number of points, the customer can redeem the credits on future in-store purchases.\u00a0 Loyalty points do not have an expiration date.
\n\u00a0
\nA portion of the revenue generated in a sale is allocated to the loyalty points earned.\u00a0 The amount allocated to the points earned is deferred until the loyalty points are redeemed.
\n\u00a0
\nDeferred Income
\n\u00a0
\nDeferred income represents cash payments received in advance of the Company\u2019s transfer of control of products or services to its customers and generally consists of unearned revenue from the Company\u2019s loyalty programs.\u00a0 The Company\u2019s deferred income balances were $1,047,781\u00a0and $759,060 as of December 31, 2022 and 2021, respectively, and were recorded within accrued expenses in the consolidated balance sheets.\u00a0 During the years ended December 31, 2022 and 2021, the Company recognized $1,082,994 and $1,136,135, respectively, of net revenues from amounts recorded as deferred income.\u00a0 The deferred income balance as of December 31, 2022 is expected to be recognized as revenue within the next months.
\n\u00a0
\nThe Company determined that no provision for returns or refunds was necessary as at December 31, 2022 or 2021.\u00a0
\n\u00a0
"}]},{"name":"rpt:f-402","factDimensions":{"xbrl:concept":"us-gaap:DisaggregationOfRevenueTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | December 31, | \u00a0 | \u00a0 | December 31, | \u00a0 | ||
| \u00a0 | \u00a0 | 2022 | \u00a0 | \u00a0 | 2021 | \u00a0 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Retail | \u00a0 | $ | 90,363,557 | \u00a0 | \u00a0 | $ | 114,792,191 | \u00a0 |
| Wholesale | \u00a0 | \u00a0 | 14,210,820 | \u00a0 | \u00a0 | \u00a0 | 4,701,244 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Net revenues | \u00a0 | $ | 104,574,377 | \u00a0 | \u00a0 | $ | 119,493,435 | \u00a0 |
(j)\u00a0 Cost of Sales
\n\u00a0
\nCost of sales represents costs directly related to manufacturing and distribution of the Company\u2019s products. Primary costs include raw materials, packaging, direct labor, overhead, shipping and handling, the depreciation of certain property, plant and equipment, and tariffs. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance, and property taxes. Cost of sales also includes inventory valuation adjustments. The Company recognizes the cost of sales as the associated revenues are recognized.
"}]},{"name":"rpt:f-414","factDimensions":{"xbrl:concept":"us-gaap:LesseeLeasesPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(k) Leases
\n\u00a0
\nThe Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (\u201cROU\u201d) assets and right-of-use liabilities (current and non-current) in the balance sheets. Finance lease ROU assets and ROU liabilities (current and non-current), if any, are included finance lease in the balance sheets.
\n\u00a0
\nROU assets represent the Company\u2019s right to use an underlying asset for the lease term and lease liabilities represent the Company\u2019s obligation to make lease payments arising from the lease. ROU assets are classified as a finance lease or an operating lease. A finance lease is a lease in which 1) ownership of the property transfers to the lessee by the end of the lease term; 2) the lease grants the lessee an option to purchase the underlying asset that the lessee is reasonably certain to exercise; 3) the lease is for a major part of the remaining economic life of the underlying asset; 4) The present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already included in the lease payments equals or exceeds substantially all of the fair value; or 5) the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. The Company classifies a lease as an operating lease when it does not meet any one of these criteria.
\n\u00a0
\n \n \nROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of the Company\u2019s leases do not provide an implicit rate, the incremental borrowing rate is used based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. The ROU assets also include any lease payments made and excludes lease incentives. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.
\n\u00a0
\nFor finance leases, lease expenses are the sum of interest on the lease obligations and amortization of the ROU assets, resulting in a front-loaded expense pattern. ROU assets are amortized based on the lesser of the lease term and the useful life of the leased asset according to the property and equipment accounting policy. If ownership of the ROU assets transfers to the Company at the end of the lease term or if the Company is reasonably certain to exercise a purchase option, amortization is calculated using the estimated useful life of the leased asset, according to the property and equipment accounting policy. For operating leases, the lease expenses are generally recognized on a straight-line basis over the lease term and recorded to lease expenses or, in the case of leases directly related to the cultivation of cannabis, in cost of goods sold in the statements of operations and comprehensive loss.
\n\u00a0
\nThe Company has elected to apply the practical expedient, for each class of underlying asset, except real estate leases, to not separate non-lease components from the associated lease components of the lessee\u2019s contract and account for both components as a single lease component.
\n\u00a0
\nThe Company has elected not to recognize ROU assets and lease liabilities for short-term leases that have a lease term of 12 months or less that do not include an option to purchase the underlying asset that the Company is reasonably certain to exercise. Short-term leases include real estate and vehicles and are not significant in comparison to the Company\u2019s overall lease portfolio. The Company continues to recognize the lease payments associated with these leases as expenses on a straight-line basis over the lease term.
"}]},{"name":"rpt:f-415","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(l) Income taxes
\n\u00a0
\nIncome taxes are comprised of current and deferred taxes. These taxes are accounted for using the asset and liability method of accounting for income taxes under ASC 740 Income Taxes. Deferred tax is recognized on the difference between the carrying amount of an asset or a liability, as reflected in the consolidated financial statements, and the corresponding tax base used in the computation of income for tax purposes (\"temporary difference\") and measured using the enacted tax rates and laws as at the balance sheet date that are expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date. Management assesses the likelihood that a deferred tax asset will be realized, and a valuation allowance is provided to the extent that it is more likely than not that all or a portion of a deferred tax asset will not be realized. If it is subsequently determined that the Company will be able to realize deferred tax assets in excess of the net recorded amount, then the valuation allowance will be adjusted accordingly in the period in which this determination is made.\u00a0Current tax is recognized in connection with income for tax purposes, unrecognized tax benefits and the recovery of tax paid in a prior period and measured using the enacted tax rates and laws applicable to the taxation period during which the income for tax purposes arose. An unrecognized tax benefit may arise in connection with a period that has not yet been reviewed by the relevant tax authority. A change in the recognition or measurement of an unrecognized tax benefit is reflected in the period during which the change occurs.
\n\u00a0
\nThe Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes.
\n\u00a0
\nInterest and penalties in respect of income taxes are not recognized in the consolidated statement of operations and comprehensive loss as a component of income taxes but as a component of interest expense.
\n\u00a0
\nAs the Company operates in the cannabis industry, it is subject to the limits of U.S. Internal Revenue Code (\u201cIRC\u201d) Section 280E (\u201cSection 280E\u201d) under which the Company is only allowed to deduct expenses directly related to the cost of producing the products or cost of production.
"}]},{"name":"rpt:f-416","factDimensions":{"xbrl:concept":"plnhf:SalesAndMarketingPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(m) Sales and marketing expenses
\n\u00a0
\nThe Company expenses sales and marketing costs when incurred. Sales and marketing expense was $3,504,309 for the year ended December 31, 2022 (2021 - $5,969,792).
"}]},{"name":"rpt:f-417","factDimensions":{"xbrl:concept":"us-gaap:SellingAndMarketingExpense","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3504309"}]},{"name":"rpt:f-418","factDimensions":{"xbrl:concept":"us-gaap:SellingAndMarketingExpense","xbrl:period":"2021-01-01T00:00:00/2022-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5969792"}]},{"name":"rpt:f-419","factDimensions":{"xbrl:concept":"us-gaap:FairValueMeasurementPolicyPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(n) Fair value measurements
\n\u00a0
\nFair value is the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. Fair value measurement for invested assets are categorized into levels within a fair value hierarchy based on the nature of the valuation inputs (Levels 1, 2 or 3). The three levels are defined based on the observability of significant inputs to the measurement, as follows:
\n\u00a0
\n| \u00a0 | \u25cf | Level 1: quoted prices (unadjusted) in active markets for identical or liabilities; |
| \u00a0 | \u25cf | Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and |
| \u00a0 | \u25cf | Level 3: one or more significant inputs used in a valuation technique are unobservable in determining fair values of the asset or liability |
\u00a0
\nDetermination of fair value and the resulting hierarchy requires the use of observable market data whenever available. The classification of an asset or liability in the hierarchy is based upon the lowest level of input that is significant to the measurement of fair value. The carrying value of the Company\u2019s cash, accounts receivable, deposits, accounts payable, accrued expenses, and notes payable approximate their fair value due to their short-term nature. Warrant liability is measured based on level 1 inputs (Note 11).
\n\u00a0
\nThe\u00a0Company's\u00a0prepaid and other current assets, long lived assets, including property and equipment, intangible assets and goodwill are measured at fair value when there is an indicator of impairment and are recorded at fair value only when an impairment charge is recognized.
"}]},{"name":"rpt:f-420","factDimensions":{"xbrl:concept":"us-gaap:EarningsPerSharePolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(o) Loss\u00a0per share
\n\u00a0
\nBasic net loss per share is computed by dividing reported net loss by the weighted average number of common shares outstanding for the reported period. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock of the Company during the reporting period. Diluted earnings per share is computed by dividing net loss by the sum of the weighted average number of common shares and the number of potentially dilutive common share equivalents outstanding during the period. Potential dilutive common share equivalents consist of the incremental common shares issuable upon the exercise of vested share options. When the Company is incurring losses, basic and diluted loss per share are the same since including the exercise of outstanding options and warrants in the diluted loss per share calculation would be antidilutive.\u00a0
"}]},{"name":"rpt:f-421","factDimensions":{"xbrl:concept":"us-gaap:SegmentReportingPolicyPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(p) Operating segments
\n\u00a0
\nOperating segments are components of the Company that engage in business activities which generate revenues and incur expenses (including intercompany revenues and expenses related to transactions conducted with other components of the Company). The operations of an operating segment are distinct, and the operating results are regularly reviewed by the chief operating decision maker (\u201cCODM\u201d) for the purposes of resource allocation decisions and assessing its performance. The Company's Co-Chief Executive Officers are the Company's CODM.
\n\u00a0
\nThe Company determined that each of its locations represents an operating segment. These operating segments have been aggregated into a single reportable segment as the Company\u00a0operates\u00a0as a vertically integrated cannabis company with dispensary, cultivation, production and distribution operations in the state of Nevada and dispensary, cultivation and distribution\u00a0operations in\u00a0the state of California.
\n\u00a0
\nAs at December 31, 2022 and 2021, all the Company\u2019s non-current assets were located in the United States and 100% of the Company\u2019s revenue was generated in the United States.
\n\u00a0
"}]},{"name":"rpt:f-422","factDimensions":{"xbrl:concept":"us-gaap:ConcentrationRiskPercentage1","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:SalesRevenueNetMember","us-gaap:ConcentrationRiskByTypeAxis":"us-gaap:GeographicConcentrationRiskMember","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"1","decimals":0}]},{"name":"rpt:f-423","factDimensions":{"xbrl:concept":"us-gaap:UseOfEstimates","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(q)\u00a0 Critical accounting estimates and judgements
\n\u00a0
\nThe preparation of consolidated financial statements in conformity with GAAP requires the Company\u2019s management to make judgements, estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements. Although these estimates are based on management\u2019s best knowledge of the amount, event or actions, actual results may differ from those estimates. Estimates and judgements are continuously evaluated and are based on management\u2019s experience and other factors, including expectations of future events that are believed to be reasonable.\u00a0
\n\u00a0
\nRevisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.
\n\u00a0
\nFinancial statement areas that require significant judgments are as follows:
\n\u00a0
\nEstimated useful lives and depreciation of property and equipment, right-of-use assets
\n\u00a0
\nDepreciation and amortization of property and equipment, right-of-use assets and intangible assets are dependent upon estimates of useful lives, which are determined through the exercise of judgment. Impairment of definite long-lived assets is influenced by judgment in defining a an asset group\u00a0and determining the indicators of impairment, and estimates used to measure impairment losses. Refer to Notes 6,\u00a07 and 8 for further information.
\n\u00a0
\nLeases
\n\u00a0
\nThe Company applies judgement in determining whether a contract contains a lease and if a lease is classified as an operating lease or a finance lease.
\n\u00a0
\nThe Company determines the lease term as the non-cancellable term of the lease, which may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The lease term is used in determining classification between operating lease and finance lease, calculating the lease liability and determining the incremental borrowing rate.\u00a0 The Company has several lease contracts that include extension and termination options. The Company applies judgement in evaluating whether it is reasonably certain to exercise the option to renew or terminate the lease. That is, it considers all relevant factors that create an economic incentive for it to exercise either the renewal or termination. After the commencement date of the lease, the Company reassesses the lease term if there is a significant event or change in circumstances that is within its control and affects its ability to exercise or not to exercise the option to renew or to terminate (e.g., construction of significant leasehold improvements or significant customization to the leased asset).
\n\u00a0
\nThe Company is required to discount lease payments using the rate implicit in the lease if that rate is readily available. If that rate cannot be readily determined, the lessee is required to use its incremental borrowing rate. The Company generally uses the incremental borrowing rate when initially recording real estate leases.\u00a0 Information from the lessor regarding the fair value of underlying assets and initial direct costs incurred by the lessor related to the leased assets is not available. The Company determines the incremental borrowing rate as the interest rate the Company would pay to borrow over a similar term the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.
\n\u00a0
\nDefinition of a business
\n\u00a0
\nDetermination of what constitutes a business for purposes of acquisition accounting requires significant judgement.\u00a0 ASC 805 notes that if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, the set is not considered a business. However, the exact quantitative threshold is not explicitly defined. During the year ended December 31, 2022, the Company completed one acquisition, further described in Note 7.
\n\u00a0
\nAsset Impairment
\n\u00a0
\nAsset impairment tests require the allocation of assets to asset groups, where appropriate, which requires significant judgment and interpretation with respect to the integration between the assets and shared resources. Asset impairment tests require the determination of whether there is an indication of impairment. The assessment of whether an indication of impairment exists is performed at the end of each reporting period and requires the application of judgment, historical experience, and external and internal sources of information.
\n\u00a0
\n \n \nDeferred tax assets and uncertain tax positions
\n\u00a0
\nThe Company recognizes deferred tax assets and liabilities based on the differences between the consolidated financial statement carrying amounts and the respective tax bases of its assets and liabilities. The Company measures deferred tax assets and liabilities using current enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. The Company routinely evaluates the likelihood of realizing the benefit of its deferred tax assets and may record a valuation allowance if, based on all available evidence, it determines that some portion of the tax benefit will not be realized.
\n\u00a0
\nIn evaluating the ability to recover deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax-planning strategies and results of operations. In projecting future taxable income, the Company considers historical results and incorporates assumptions about the amount of future pretax operating income adjusted for items that do not have tax consequences. The Company\u2019s assumptions regarding future taxable income are consistent with the plans and estimates that are used to manage its underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income (loss). The income tax expense, deferred tax assets and liabilities and liabilities for unrecognized tax benefits reflect the Company\u2019s best assessment of estimated current and future taxes to be paid. Deferred tax asset valuation allowances and liabilities for unrecognized tax benefits require significant judgment regarding applicable statutes and their related interpretation, the status of various income tax audits and the Company\u2019s particular facts and circumstances. Although the Company believes that the judgments and estimates discussed herein are reasonable, actual results, including forecasted COVID-19 business recovery, could differ, and the Company may be exposed to losses or gains that could be material. To the extent the Company prevails in matters for which a liability has been established or is required to pay amounts in excess of the established liability, the effective income tax rate in a given financial statement period could be materially affected.
\n\u00a0
\nKey estimates in these consolidated financial statements include:
\n\u00a0
\nShare-based compensation
\n\u00a0
\nThe Company uses the Black-Scholes valuation model to determine the fair value of options and warrants granted to employees and non-employees under share-based payment arrangements, where appropriate. In estimating fair value, management is required to make certain assumptions and estimates such as the expected term of the instrument, volatility of the Company\u2019s future share price, risk free rates, future dividend yields and estimated forfeitures at the initial grant date, by reference to the underlying terms of the instrument, and the Company\u2019s experience with similar instruments. Changes in assumptions used to estimate fair value could result in materially different results. Refer to Note 12 for further information.
\n\u00a0
\nValuation of inventory
\n\u00a0
\nInventory is comprised of raw materials, work-in-progress and finished goods. Cannabis and hemp costs include expenditures directly related to the manufacturing process as well as suitable portions of related production overheads, based on normal operating capacity. At the end of each reporting period, the Company performs an assessment of inventory and records inventory valuation adjustments for excess and obsolete inventories based on the estimated forecast of product demand, production requirements, market conditions, regulatory environment, and spoilage. A reserve is estimated to ensure the inventory balance at the end of the year reflects the estimates of product the Company expects to sell in the next year. Changes in the regulatory structure, lack of retail distribution locations or lack of consumer demand could result in future inventory reserves.
\n\u00a0
\nImpairment of indefinite life intangible assets and goodwill
\n\u00a0
\nThe assessment of whether an indication of impairment exists is performed at the end of each reporting period and requires the application of judgment, historical experience, and external and internal sources of information. The Company makes estimates in determining the future cash flows and discount rates in the quantitative impairment test to compare the fair value to the carrying value.
"}]},{"name":"rpt:f-424","factDimensions":{"xbrl:concept":"us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(r) Accounting standards issued but not yet effective
\n\u00a0
\nBusiness Combinations
\n\u00a0
\nIn October 2021, the FASB issued ASU 2021-08, Accounting for Contract Assets and Contact Liabilities from Contracts with Customers (\u201cASU 2021-08\u201d) (\u201cASC 805\u201d). ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities from acquired contracts using the revenue recognition guidance under ASC 606 in order to align the recognition of a contract liability with the definition of performance obligation. This approach differences from the current requirement to measure contract assets and contract liabilities acquired in a business combination at fair value. ASU 2021-08 is effective for financial statements of non-public business entities issued for fiscal years beginning after December 15, 2023 and early adoption is permitted. The Company is currently evaluating the effect of adopting this ASU.
"}]},{"name":"rpt:f-425","factDimensions":{"xbrl:concept":"us-gaap:SaleLeasebackTransactionsPolicy","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"(s) Sale-leaseback transactions
\n\u00a0
\nFrom time to time, the Company may enter into sale-leaseback transactions to finance certain property acquisitions and capital expenditures, pursuant to which the Company sells the property to a third party and agrees to lease the property back for a certain period of time. To determine whether the transfer of the property should be accounted for as a sale, the Company evaluates whether it has transferred control to the third party in accordance with the revenue recognition guidance set forth in ASC 606.
\n\u00a0
\nIf the transfer of the asset is deemed to be a sale at market terms, the Company recognizes the transaction price for the sale based on the cash proceeds received, derecognizes the carrying amount of the underlying asset and recognizes a gain or loss in the consolidated statements of operations and comprehensive loss for any difference between the carrying value of the asset and the transaction price. The Company then accounts for the leaseback in accordance with its lease accounting policy.
\n\u00a0
\nIf the transfer of the asset is determined not to be a sale at market terms, the Company accounts for the transaction as a financing arrangement, and accordingly no asset sale is recognized. The Company retains the historical costs of the property and the related accumulated depreciation on its books and continues to depreciate the property over the lesser of its remaining useful life or its initial lease term. The asset is presented within property and equipment, net on the consolidated balance sheets. All proceeds from these transactions are accounted for as finance obligations and presented as non-current obligations on the consolidated balance sheets. A portion of the lease payments is recognized as a reduction of the financing obligation and a portion is recognized as interest expense based on an imputed interest rate.
"}]},{"name":"rpt:f-426","factDimensions":{"xbrl:concept":"us-gaap:InventoryDisclosureTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| 4. Inventory\u00a0 |
\u00a0
\nFinished goods inventory consists of dried cannabis, concentrates, edibles, and other products that are complete and available for sale (both internally generated inventory and third-party products purchased in the wholesale market). Work in process inventory consists of cannabis after harvest, in the processing stage. Packaging and miscellaneous consist of consumables for use in the transformation of biological assets and other inventory used in production of finished goods, non-cannabis merchandise and food and beverage items.\u00a0 The Company\u2019s inventory is comprised of:
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Raw materials | \u00a0 | $ | 5,209,667 | \u00a0 | $ | 3,093,646 | ||
Packaging and miscellaneous | \u00a0 | 1,584,659 | \u00a0 | 1,825,514 | ||||
Work in progress | \u00a0 | 1,965,052 | \u00a0 | 2,883,955 | ||||
Finished goods | \u00a0 | 4,245,461 | \u00a0 | 6,422,254 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | $ | 13,004,839 | \u00a0 | $ | 14,225,369 |
\u00a0
\nCost of Inventory is recognized as an expense when sold and included in cost of goods sold. During the year ended December 31, 2022, the Company recognized $56,599,623 (2021 - $53,485,458) of inventory expensed to cost of goods sold.
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-427","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfInventoryCurrentTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Raw materials | \u00a0 | $ | 5,209,667 | \u00a0 | $ | 3,093,646 | ||
Packaging and miscellaneous | \u00a0 | 1,584,659 | \u00a0 | 1,825,514 | ||||
Work in progress | \u00a0 | 1,965,052 | \u00a0 | 2,883,955 | ||||
Finished goods | \u00a0 | 4,245,461 | \u00a0 | 6,422,254 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | $ | 13,004,839 | \u00a0 | $ | 14,225,369 |
| 5. Prepaid expenses and other current assets |
\u00a0
\n \n| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Security deposits | \u00a0 | $ | 1,399,424 | \u00a0 | $ | 2,287,596 | ||
Advertising and Marketing | \u00a0 | - | \u00a0 | 306,415 | ||||
Prepaid rent | \u00a0 | 348,433 | \u00a0 | 218,599 | ||||
Insurance | \u00a0 | 678,402 | \u00a0 | 804,608 | ||||
License fees | \u00a0 | 776,717 | \u00a0 | 36,008 | ||||
Miscellaneous | \u00a0 | 607,418 | \u00a0 | 324,298 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | $ | 3,810,394 | \u00a0 | $ | 3,977,524 |
| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Security deposits | \u00a0 | $ | 1,399,424 | \u00a0 | $ | 2,287,596 | ||
Advertising and Marketing | \u00a0 | - | \u00a0 | 306,415 | ||||
Prepaid rent | \u00a0 | 348,433 | \u00a0 | 218,599 | ||||
Insurance | \u00a0 | 678,402 | \u00a0 | 804,608 | ||||
License fees | \u00a0 | 776,717 | \u00a0 | 36,008 | ||||
Miscellaneous | \u00a0 | 607,418 | \u00a0 | 324,298 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | $ | 3,810,394 | \u00a0 | $ | 3,977,524 |
| 6. Property and equipment | \n
\u00a0
\n \n| \u00a0 | \n\u00a0 | \nLand and | \n \n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \nLeasehold | \n \n | \u00a0 | \nConstruction | \n \n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n|||
| \u00a0 | \n\u00a0 | \nImprovements | \n \n | \u00a0 | \nBuildings | \n \n | \u00a0 | \nEquipment | \n \n | \u00a0 | \nImprovements | \n \n | \u00a0 | \nin Progress | \n \n | \u00a0 | \nTotal | \n \n | ||||||
Gross carrying amount | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
At December 31, 2020 | \n \u00a0 | \n$ | \n625,146 | \n\n | \u00a0 | \n$ | \n1,707,894 | \n\n | \u00a0 | \n$ | \n6,237,256 | \n\n | \u00a0 | \n$ | \n30,448,042 | \n\n | \u00a0 | \n$ | \n3,367,255 | \n\n | \u00a0 | \n$ | \n42,385,593 | \n\n |
Additions | \n \u00a0 | \n\n | 5,153 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 3,057,631 | \n\n | \u00a0 | \n\n | 10,663,811 | \n\n | \u00a0 | \n\n | 12,368,056 | \n\n | \u00a0 | \n\n | 26,094,651 | \n\n |
Transfers | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 1,927,109 | \n\n | \u00a0 | \n\n | 13,680,522 | \n\n | \u00a0 | \n\n | (15,607,631 | \n) | \n\u00a0 | \n\n | - | \n\n |
Disposals | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (116,755 | \n) | \n\u00a0 | \n\n | (74,004 | \n) | \n\u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (190,759 | \n) | \n
At December 31, 2021 | \n \u00a0 | \n\n | 630,299 | \n\n | \u00a0 | \n\n | 1,707,894 | \n\n | \u00a0 | \n\n | 11,105,241 | \n\n | \u00a0 | \n\n | 54,718,371 | \n\n | \u00a0 | \n\n | 127,680 | \n\n | \u00a0 | \n\n | 68,289,485 | \n\n |
Additions | \n \u00a0 | \n\n | 5,843,295 | \n\n | \u00a0 | \n\n | 12,756,048 | \n\n | \u00a0 | \n\n | 1,703,190 | \n\n | \u00a0 | \n\n | 2,722,710 | \n\n | \u00a0 | \n\n | 9,515,734 | \n\n | \u00a0 | \n\n | 32,540,977 | \n\n |
Transfers | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 6,114,711 | \n\n | \u00a0 | \n\n | (6,114,711 | \n) | \n\u00a0 | \n\n | - | \n\n |
Disposals | \n \u00a0 | \n\n | (99,083 | \n) | \n\u00a0 | \n\n | (500,917 | \n) | \n\u00a0 | \n\n | (8,786 | \n) | \n\u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (608,786 | \n) | \n
At December 31, 2022 | \n \u00a0 | \n$ | \n6,374,511 | \n\n | \u00a0 | \n$ | \n13,963,025 | \n\n | \u00a0 | \n$ | \n12,799,645 | \n\n | \u00a0 | \n$ | \n63,555,792 | \n\n | \u00a0 | \n$ | \n3,528,703 | \n\n | \u00a0 | \n$ | \n100,221,676 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Depreciation | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
At December 31, 2020 | \n \u00a0 | \n$ | \n127,931 | \n\n | \u00a0 | \n$ | \n203,750 | \n\n | \u00a0 | \n$ | \n2,259,925 | \n\n | \u00a0 | \n$ | \n7,720,062 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n10,311,668 | \n\n |
Additions | \n \u00a0 | \n\n | 51,366 | \n\n | \u00a0 | \n\n | 42,697 | \n\n | \u00a0 | \n\n | 1,542,438 | \n\n | \u00a0 | \n\n | 5,576,595 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 7,213,096 | \n\n |
Transfers & disposals | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (1,197 | \n) | \n\u00a0 | \n\n | (12,359 | \n) | \n\u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (13,556 | \n) | \n
At December 31, 2021 | \n \u00a0 | \n\n | 179,297 | \n\n | \u00a0 | \n\n | 246,447 | \n\n | \u00a0 | \n\n | 3,801,166 | \n\n | \u00a0 | \n\n | 13,284,298 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 17,511,208 | \n\n |
Additions | \n \u00a0 | \n\n | 52,225 | \n\n | \u00a0 | \n\n | 303,593 | \n\n | \u00a0 | \n\n | 2,537,587 | \n\n | \u00a0 | \n\n | 8,365,292 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 11,258,697 | \n\n |
Transfers & disposals | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (9,392 | \n) | \n\u00a0 | \n\n | (4,888 | \n) | \n\u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (14,280 | \n) | \n
At December 31, 2022 | \n \u00a0 | \n$ | \n231,522 | \n\n | \u00a0 | \n$ | \n540,648 | \n\n | \u00a0 | \n$ | \n6,333,865 | \n\n | \u00a0 | \n$ | \n21,649,590 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n28,755,625 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Carrying amount | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
At December 31, 2021 | \n \u00a0 | \n$ | \n451,002 | \n\n | \u00a0 | \n$ | \n1,461,447 | \n\n | \u00a0 | \n$ | \n7,304,075 | \n\n | \u00a0 | \n$ | \n41,434,073 | \n\n | \u00a0 | \n$ | \n127,680 | \n\n | \u00a0 | \n$ | \n50,778,277 | \n\n |
At December 31, 2022 | \n \u00a0 | \n$ | \n6,142,989 | \n\n | \u00a0 | \n$ | \n13,422,377 | \n\n | \u00a0 | \n$ | \n6,465,780 | \n\n | \u00a0 | \n$ | \n41,906,202 | \n\n | \u00a0 | \n$ | \n3,528,703 | \n\n | \u00a0 | \n$ | \n71,466,051 | \n\n |
\u00a0
\nFor the year ended December 31, 2022 depreciation expense was $11,258,697 (2021 - $7,213,096) of which $3,293,443 (2021 \u2013 $1,922,713) was included in cost of goods sold.
\n\u00a0
\nDuring the year ended December 31, 2022 the Company transferred $6,114,711 (2021 - $13,680,522) and (2021 - $1,927,109) of costs from Construction in Progress to Leasehold Improvements and Equipment, respectively, upon completion of the related projects.
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-457","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \nLand and | \n \n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \nLeasehold | \n \n | \u00a0 | \nConstruction | \n \n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n|||
| \u00a0 | \n\u00a0 | \nImprovements | \n \n | \u00a0 | \nBuildings | \n \n | \u00a0 | \nEquipment | \n \n | \u00a0 | \nImprovements | \n \n | \u00a0 | \nin Progress | \n \n | \u00a0 | \nTotal | \n \n | ||||||
Gross carrying amount | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
At December 31, 2020 | \n \u00a0 | \n$ | \n625,146 | \n\n | \u00a0 | \n$ | \n1,707,894 | \n\n | \u00a0 | \n$ | \n6,237,256 | \n\n | \u00a0 | \n$ | \n30,448,042 | \n\n | \u00a0 | \n$ | \n3,367,255 | \n\n | \u00a0 | \n$ | \n42,385,593 | \n\n |
Additions | \n \u00a0 | \n\n | 5,153 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 3,057,631 | \n\n | \u00a0 | \n\n | 10,663,811 | \n\n | \u00a0 | \n\n | 12,368,056 | \n\n | \u00a0 | \n\n | 26,094,651 | \n\n |
Transfers | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 1,927,109 | \n\n | \u00a0 | \n\n | 13,680,522 | \n\n | \u00a0 | \n\n | (15,607,631 | \n) | \n\u00a0 | \n\n | - | \n\n |
Disposals | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (116,755 | \n) | \n\u00a0 | \n\n | (74,004 | \n) | \n\u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (190,759 | \n) | \n
At December 31, 2021 | \n \u00a0 | \n\n | 630,299 | \n\n | \u00a0 | \n\n | 1,707,894 | \n\n | \u00a0 | \n\n | 11,105,241 | \n\n | \u00a0 | \n\n | 54,718,371 | \n\n | \u00a0 | \n\n | 127,680 | \n\n | \u00a0 | \n\n | 68,289,485 | \n\n |
Additions | \n \u00a0 | \n\n | 5,843,295 | \n\n | \u00a0 | \n\n | 12,756,048 | \n\n | \u00a0 | \n\n | 1,703,190 | \n\n | \u00a0 | \n\n | 2,722,710 | \n\n | \u00a0 | \n\n | 9,515,734 | \n\n | \u00a0 | \n\n | 32,540,977 | \n\n |
Transfers | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 6,114,711 | \n\n | \u00a0 | \n\n | (6,114,711 | \n) | \n\u00a0 | \n\n | - | \n\n |
Disposals | \n \u00a0 | \n\n | (99,083 | \n) | \n\u00a0 | \n\n | (500,917 | \n) | \n\u00a0 | \n\n | (8,786 | \n) | \n\u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (608,786 | \n) | \n
At December 31, 2022 | \n \u00a0 | \n$ | \n6,374,511 | \n\n | \u00a0 | \n$ | \n13,963,025 | \n\n | \u00a0 | \n$ | \n12,799,645 | \n\n | \u00a0 | \n$ | \n63,555,792 | \n\n | \u00a0 | \n$ | \n3,528,703 | \n\n | \u00a0 | \n$ | \n100,221,676 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Depreciation | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
At December 31, 2020 | \n \u00a0 | \n$ | \n127,931 | \n\n | \u00a0 | \n$ | \n203,750 | \n\n | \u00a0 | \n$ | \n2,259,925 | \n\n | \u00a0 | \n$ | \n7,720,062 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n10,311,668 | \n\n |
Additions | \n \u00a0 | \n\n | 51,366 | \n\n | \u00a0 | \n\n | 42,697 | \n\n | \u00a0 | \n\n | 1,542,438 | \n\n | \u00a0 | \n\n | 5,576,595 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 7,213,096 | \n\n |
Transfers & disposals | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (1,197 | \n) | \n\u00a0 | \n\n | (12,359 | \n) | \n\u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (13,556 | \n) | \n
At December 31, 2021 | \n \u00a0 | \n\n | 179,297 | \n\n | \u00a0 | \n\n | 246,447 | \n\n | \u00a0 | \n\n | 3,801,166 | \n\n | \u00a0 | \n\n | 13,284,298 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 17,511,208 | \n\n |
Additions | \n \u00a0 | \n\n | 52,225 | \n\n | \u00a0 | \n\n | 303,593 | \n\n | \u00a0 | \n\n | 2,537,587 | \n\n | \u00a0 | \n\n | 8,365,292 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 11,258,697 | \n\n |
Transfers & disposals | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (9,392 | \n) | \n\u00a0 | \n\n | (4,888 | \n) | \n\u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | (14,280 | \n) | \n
At December 31, 2022 | \n \u00a0 | \n$ | \n231,522 | \n\n | \u00a0 | \n$ | \n540,648 | \n\n | \u00a0 | \n$ | \n6,333,865 | \n\n | \u00a0 | \n$ | \n21,649,590 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n28,755,625 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Carrying amount | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
At December 31, 2021 | \n \u00a0 | \n$ | \n451,002 | \n\n | \u00a0 | \n$ | \n1,461,447 | \n\n | \u00a0 | \n$ | \n7,304,075 | \n\n | \u00a0 | \n$ | \n41,434,073 | \n\n | \u00a0 | \n$ | \n127,680 | \n\n | \u00a0 | \n$ | \n50,778,277 | \n\n |
At December 31, 2022 | \n \u00a0 | \n$ | \n6,142,989 | \n\n | \u00a0 | \n$ | \n13,422,377 | \n\n | \u00a0 | \n$ | \n6,465,780 | \n\n | \u00a0 | \n$ | \n41,906,202 | \n\n | \u00a0 | \n$ | \n3,528,703 | \n\n | \u00a0 | \n$ | \n71,466,051 | \n\n |
| 7. Intangible assets and goodwill | \n
\u00a0
\n \n| \u00a0 | \n\u00a0 | \nRetail Dispensary Santa Ana | \n \n | \u00a0 | \nRetail Dispensary Clark County | \n \n | \u00a0 | \nCultivation and Production Clark County | \n \n | \u00a0 | \nMaster License Florida | \n \n | \u00a0 | \nCultivation Coalinga CA Other Intangibles | \n \n | \u00a0 | \nCultivation Coalinga CA Goodwill | \n \n | \u00a0 | \nOther | \n \n | \u00a0 | \nTotal | \n \n | ||||||||
Gross | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
carrying amount | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Balance, December 31, 2020 | \n \u00a0 | \n$ | \n6,151,343 | \n\n | \u00a0 | \n$ | \n690,000 | \n\n | \u00a0 | \n$ | \n709,798 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n7,551,141 | \n\n |
Additions | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 55,846,866 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 55,846,866 | \n\n |
Balance at December 31, 2021 | \n \u00a0 | \n\n | 6,151,343 | \n\n | \u00a0 | \n\n | 690,000 | \n\n | \u00a0 | \n\n | 709,798 | \n\n | \u00a0 | \n\n | 55,846,866 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 63,398,007 | \n\n |
Additions | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 13,180,000 | \n\n | \u00a0 | \n\n | 25,802,688 | \n\n | \u00a0 | \n\n | 30,000 | \n\n | \u00a0 | \n\n | 39,012,688 | \n\n |
Impairment loss | \n \u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\n | (6,947,778 | \n) | \n\u00a0 | \n\n | (25,802,688 | \n) | \n\u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\n | (32,750,466 | \n) | \n
Balance at December 31, 2022 | \n \u00a0 | \n$ | \n6,151,343 | \n\n | \u00a0 | \n$ | \n690,000 | \n\n | \u00a0 | \n$ | \n709,798 | \n\n | \u00a0 | \n$ | \n55,846,866 | \n\n | \u00a0 | \n$ | \n6,232,222 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n30,000 | \n\n | \u00a0 | \n$ | \n69,660,229 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Amortization | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
At December 31, 2020 | \n \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n |
Transfers & disposals | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
At December 31, 2021 | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
Additions | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 372,222 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 372,222 | \n\n |
At December 31, 2022 | \n \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n372,222 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n372,222 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Carrying amount | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Balance at December 31, 2021 | \n \u00a0 | \n$ | \n6,151,343 | \n\n | \u00a0 | \n$ | \n690,000 | \n\n | \u00a0 | \n$ | \n709,798 | \n\n | \u00a0 | \n$ | \n55,846,866 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n63,398,007 | \n\n |
Balance at December 31, 2022 | \n \u00a0 | \n$ | \n6,151,343 | \n\n | \u00a0 | \n$ | \n690,000 | \n\n | \u00a0 | \n$ | \n709,798 | \n\n | \u00a0 | \n$ | \n55,846,866 | \n\n | \u00a0 | \n$ | \n5,860,000 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n30,000 | \n\n | \u00a0 | \n$ | \n69,288,007 | \n\n |
\u00a0
\nNGW Acquisition
\n\u00a0
\nOn March 2, 2022, the Company acquired 100% ownership interest of Next Green Wave Holdings, Inc. (\u201cNGW\u201d) and accounted for the transaction as a business combination pursuant to ASC 805.
\n\u00a0
\nNGW was incorporated in 2011 and was formed for the purpose of cultivating and selling cannabis products in the state of California, where it owns and operates a cultivation and manufacturing facility.\u00a0 The Company executed the NGW transaction in order to introduce certain of its brands to the California market; complement its dispensary operations in Santa Ana, California; and expand its California revenue base.
\n\u00a0
\nThe aggregate purchase price for the NGW transaction was $57,574,938 and consisted of $14,788 in cash consideration, $1,239,818 in replacement options and $56,320,332 in share consideration. The share consideration was comprised of 21,361,002 common shares of the Company at a fair value of per common share, which were issued on March 2, 2022.
\n\u00a0
\n \n \nThe following table summarizes the allocation of consideration exchanged to the estimated fair value of the tangible and intangible assets acquired:
\n\u00a0
\n \nConsideration paid: | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Cash | \u00a0 | $ | 14,788 | |
Issuance of Class A Shares | \u00a0 | 56,320,332 | ||
Issuance of replacement options | \u00a0 | 1,239,818 | ||
| \u00a0 | \u00a0 | $ | 57,574,938 |
\u00a0
\n \nFair value of net assets acquired: | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Cash | \n \u00a0 | \n$ | \n1,493,922 | \n\n |
Inventory | \n \u00a0 | \n\n | 3,077,367 | \n\n |
Accounts Receivable | \n \u00a0 | \n\n | 1,374,142 | \n\n |
Property, plant and equipment | \n \u00a0 | \n\n | 16,229,350 | \n\n |
Intangible assets | \n \u00a0 | \n\n | 13,180,000 | \n\n |
Goodwill | \n \u00a0 | \n\n | 25,802,688 | \n\n |
Accounts Payable and Accrued Liabilities | \n \u00a0 | \n\n | (233,158 | \n) | \n
Income taxes payable | \n \u00a0 | \n\n | (125,445 | \n) | \n
Deferred tax liability | \n \u00a0 | \n\n | (3,223,928 | \n) | \n
| \u00a0 | \n\u00a0 | \n$ | \n57,574,938 | \n\n |
\u00a0
\nThe purchase price allocations for the NGW transaction reflect various fair value estimates and analyses relating to the determination of fair value of certain tangible and intangible assets acquired and residual goodwill. The Company determined the estimated fair value of the acquired working capital, and identifiable intangible assets and goodwill after review and consideration of relevant information including discounted cash flow analyses, market data and management\u2019s estimates, prepared by an independent valuation firm. The estimated fair value of acquired working capital was determined to approximate carrying value.
\n\u00a0
\nThe goodwill arising from the NGW transaction consists of expected synergies from combining operations of the Company and NGW, and intangible assets not qualifying for separate recognition such as formulations, proprietary technologies and acquired know-how. None of the goodwill is deductible for tax purposes.
\n\u00a0
\nNGW\u2019s state cannabis licenses and brands represented identifiable intangible assets acquired in the amounts of $11,840,000 and $1,340,000, respectively. The NGW cannabis licenses acquired have an indefinite life and as such will not be subject to amortization while the brands have a definite useful life of years. As of December 31, 2022, the Company evaluated whether intangible assets and goodwill showed any indicators of impairment, and it was determined that such indicators existed.\u00a0 As a result of the Company\u2019s analysis, it was determined that the brands and licenses were impaired, resulting in the Company recording an impairment charge of $6,947,778.
\n\u00a0
\nIn connection with the NGW transaction, the Company expensed $1,238,379 of acquisition-related costs, which have been included in general and administrative expenses on the Company\u2019s consolidated statement of operations and comprehensive loss for the year ended December 31, 2022.
\n\u00a0
\n \n \nNGW's post-acquisition revenues, gross profit and net income included in the Company's results for the period since the closing of the transaction were $7,557,860, $373,025 and ($37,555). The following tables reflects the revenue, gross profit and comprehensive income (loss) that would have been reported if the acquisition had occurred at the beginning of the years indicated:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \nYear Ended December 31, 2022 | \n \n | \u00a0 | \nYear Ended December 31, 2021 | \n \n | ||||||||||||||||||
| \u00a0 | \n\u00a0 | \nAs Reported | \n \n | \u00a0 | \nNGW | \n \n | \u00a0 | \nPro Forma | \n \n | \u00a0 | \nAs Reported | \n \n | \u00a0 | \nNGW | \n \n | \u00a0 | \nPro Forma | \n \n | ||||||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Revenue, net of discounts | \n \u00a0 | \n$ | \n104,574,377 | \n\n | \u00a0 | \n$ | \n870,651 | \n\n | \u00a0 | \n$ | \n105,445,028 | \n\n | \u00a0 | \n$ | \n119,493,435 | \n\n | \u00a0 | \n$ | \n15,931,107 | \n\n | \u00a0 | \n$ | \n135,424,542 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Gross Profit | \n \u00a0 | \n\n | 47,974,754 | \n\n | \u00a0 | \n\n | (131,700 | \n) | \n\u00a0 | \n\n | 47,843,054 | \n\n | \u00a0 | \n\n | 66,007,977 | \n\n | \u00a0 | \n\n | 6,330,381 | \n\n | \u00a0 | \n\n | 72,338,358 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Comprehensive income (loss) for the period | \n \u00a0 | \n\n | (48,980,300 | \n) | \n\u00a0 | \n\n | (868,125 | \n) | \n\u00a0 | \n\n | (49,848,425 | \n) | \n\u00a0 | \n\n | (19,460,952 | \n) | \n\u00a0 | \n\n | 1,254,529 | \n\n | \u00a0 | \n\n | (18,206,423 | \n) | \n
\u00a0
\nThe carrying value of goodwill in each reporting unit is indicative of the expected growth and development of the business. In the fourth quarter of fiscal 2022, the Company identified qualitative indicators of impairment as a result of a downturn in the wholesale pricing of cannabis.\u00a0 The reduction in the price of wholesale cannabis resulted in a downward adjustment of the future financial forecasts for the Company\u2019s NGW business, which indicated that impairment of the goodwill asset was a more-likely-than-not outcome. A qualitative step zero impairment test was performed on the NGW business which indicated a potential impairment. The Company conducted a quantitative impairment analysis of its NGW reporting unit using the income approach as at December 31, 2022.
\n\u00a0
\nThe recoverable amount of the reporting unit to which goodwill is allocated and the asset group to which indefinite life intangibles are allocated were determined based on fair value using Level 3 inputs in a discounted cash flow analysis. Management tested the NGW asset group for the definite lived assets impairment. The result was impairment for the definite lived assets of the NGW asset group. Where applicable, the Company uses its market capitalization and comparative market multiples to corroborate discounted cash flow results. The significant assumptions applied in the determination of the recoverable amount are described below:
\n\u00a0
\n| \u00a0 | \n \u25cf | \n Cash flows: Estimated cash flows were projected based on actual operating results from internal sources as well as industry and market trends. Estimated cash flows are primarily driven by sales volumes, selling prices and operating costs. The forecasts are extended to a total of six years (and a terminal year thereafter); | \n
| \u00a0 | \n \u25cf | \n Terminal value growth rate: The terminal growth rate was based on historical and projected consumer price inflation, historical and projected economic indicators and projected industry growth; | \n
| \u00a0 | \n \u25cf | \n Post-tax discount rate: The post-tax discount rate is reflective of the reporting unit's Weighted Average Cost of Capital (\"WACC\"). The WACC was estimated based on the risk-free rate, equity risk premium, beta adjustment to the equity risk premium based on a direct comparison approach, an unsystematic risk premium, and after-tax cost of debt based on corporate bond yields; and | \n
| \u00a0 | \n\u25cf | \nTax rate: The tax rates used in determining the future cash flows were those substantively enacted at the respective valuation date. | \n
\u00a0
\nThe following table outlines the key assumptions used in calculating the recoverable amount for each CGU and operating segment tested for impairment as at December 31, 2022:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \nGoodwill impairment testing | \n
Significant estimates used by management | \n \u00a0 | \nNGW | \n
Years of cash flows before terminal value | \n \u00a0 | \n6 | \n
Discount rate | \n \u00a0 | \n19.25% | \n
Terminal value multiple | \n \u00a0 | \n
\u00a0
\nBased on the results of the goodwill impairment test, the carrying value of the NGW reporting unit exceeded the fair value and the Company recognized a pre-tax impairment loss of $25,802,688 during the year ended December 31, 2022, relating to the NGW reporting unit.
\n\u00a0
\n \n \nFlorida License Acquisition
\n\u00a0
\nOn September 28, 2021, the Florida Department of Health\u2019s Office of Medical Marijuana Use (\u201cOMMU\u201d) approved the Company to acquire a license to operate a Medical Marijuana Treatment Center issued by the Florida Department of Health from a subsidiary of Harvest Health & Recreation Inc.\u00a0 The acquisition closed with an effective date of October 1, 2021, and the Company released $55,000,000 of restricted cash that was being held in escrow to the seller in exchange for receipt of the Medical Marijuana Treatment Center license.
\n\u00a0
\nThe Company has capitalized $846,866 in costs incurred to secure the license pursuant to the license acquisition.
\n "}]},{"name":"rpt:f-574","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \nRetail Dispensary Santa Ana | \n \n | \u00a0 | \nRetail Dispensary Clark County | \n \n | \u00a0 | \nCultivation and Production Clark County | \n \n | \u00a0 | \nMaster License Florida | \n \n | \u00a0 | \nCultivation Coalinga CA Other Intangibles | \n \n | \u00a0 | \nCultivation Coalinga CA Goodwill | \n \n | \u00a0 | \nOther | \n \n | \u00a0 | \nTotal | \n \n | ||||||||
Gross | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
carrying amount | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Balance, December 31, 2020 | \n \u00a0 | \n$ | \n6,151,343 | \n\n | \u00a0 | \n$ | \n690,000 | \n\n | \u00a0 | \n$ | \n709,798 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n7,551,141 | \n\n |
Additions | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 55,846,866 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 55,846,866 | \n\n |
Balance at December 31, 2021 | \n \u00a0 | \n\n | 6,151,343 | \n\n | \u00a0 | \n\n | 690,000 | \n\n | \u00a0 | \n\n | 709,798 | \n\n | \u00a0 | \n\n | 55,846,866 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 63,398,007 | \n\n |
Additions | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 13,180,000 | \n\n | \u00a0 | \n\n | 25,802,688 | \n\n | \u00a0 | \n\n | 30,000 | \n\n | \u00a0 | \n\n | 39,012,688 | \n\n |
Impairment loss | \n \u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\n | (6,947,778 | \n) | \n\u00a0 | \n\n | (25,802,688 | \n) | \n\u00a0 | \n\u00a0 | \n\n | \u00a0 | \n\u00a0 | \n\n | (32,750,466 | \n) | \n
Balance at December 31, 2022 | \n \u00a0 | \n$ | \n6,151,343 | \n\n | \u00a0 | \n$ | \n690,000 | \n\n | \u00a0 | \n$ | \n709,798 | \n\n | \u00a0 | \n$ | \n55,846,866 | \n\n | \u00a0 | \n$ | \n6,232,222 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n30,000 | \n\n | \u00a0 | \n$ | \n69,660,229 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Amortization | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
At December 31, 2020 | \n \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n |
Transfers & disposals | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
At December 31, 2021 | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
Additions | \n \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 372,222 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 372,222 | \n\n |
At December 31, 2022 | \n \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n372,222 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n372,222 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Carrying amount | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Balance at December 31, 2021 | \n \u00a0 | \n$ | \n6,151,343 | \n\n | \u00a0 | \n$ | \n690,000 | \n\n | \u00a0 | \n$ | \n709,798 | \n\n | \u00a0 | \n$ | \n55,846,866 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n63,398,007 | \n\n |
Balance at December 31, 2022 | \n \u00a0 | \n$ | \n6,151,343 | \n\n | \u00a0 | \n$ | \n690,000 | \n\n | \u00a0 | \n$ | \n709,798 | \n\n | \u00a0 | \n$ | \n55,846,866 | \n\n | \u00a0 | \n$ | \n5,860,000 | \n\n | \u00a0 | \n$ | \n- | \n\n | \u00a0 | \n$ | \n30,000 | \n\n | \u00a0 | \n$ | \n69,288,007 | \n\n |
Consideration paid: | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Cash | \u00a0 | $ | 14,788 | |
Issuance of Class A Shares | \u00a0 | 56,320,332 | ||
Issuance of replacement options | \u00a0 | 1,239,818 | ||
| \u00a0 | \u00a0 | $ | 57,574,938 |
Fair value of net assets acquired: | \n \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Cash | \n \u00a0 | \n$ | \n1,493,922 | \n\n |
Inventory | \n \u00a0 | \n\n | 3,077,367 | \n\n |
Accounts Receivable | \n \u00a0 | \n\n | 1,374,142 | \n\n |
Property, plant and equipment | \n \u00a0 | \n\n | 16,229,350 | \n\n |
Intangible assets | \n \u00a0 | \n\n | 13,180,000 | \n\n |
Goodwill | \n \u00a0 | \n\n | 25,802,688 | \n\n |
Accounts Payable and Accrued Liabilities | \n \u00a0 | \n\n | (233,158 | \n) | \n
Income taxes payable | \n \u00a0 | \n\n | (125,445 | \n) | \n
Deferred tax liability | \n \u00a0 | \n\n | (3,223,928 | \n) | \n
| \u00a0 | \n\u00a0 | \n$ | \n57,574,938 | \n\n |
| \u00a0 | \n\u00a0 | \nYear Ended December 31, 2022 | \n \n | \u00a0 | \nYear Ended December 31, 2021 | \n \n | ||||||||||||||||||
| \u00a0 | \n\u00a0 | \nAs Reported | \n \n | \u00a0 | \nNGW | \n \n | \u00a0 | \nPro Forma | \n \n | \u00a0 | \nAs Reported | \n \n | \u00a0 | \nNGW | \n \n | \u00a0 | \nPro Forma | \n \n | ||||||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Revenue, net of discounts | \n \u00a0 | \n$ | \n104,574,377 | \n\n | \u00a0 | \n$ | \n870,651 | \n\n | \u00a0 | \n$ | \n105,445,028 | \n\n | \u00a0 | \n$ | \n119,493,435 | \n\n | \u00a0 | \n$ | \n15,931,107 | \n\n | \u00a0 | \n$ | \n135,424,542 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Gross Profit | \n \u00a0 | \n\n | 47,974,754 | \n\n | \u00a0 | \n\n | (131,700 | \n) | \n\u00a0 | \n\n | 47,843,054 | \n\n | \u00a0 | \n\n | 66,007,977 | \n\n | \u00a0 | \n\n | 6,330,381 | \n\n | \u00a0 | \n\n | 72,338,358 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Comprehensive income (loss) for the period | \n \u00a0 | \n\n | (48,980,300 | \n) | \n\u00a0 | \n\n | (868,125 | \n) | \n\u00a0 | \n\n | (49,848,425 | \n) | \n\u00a0 | \n\n | (19,460,952 | \n) | \n\u00a0 | \n\n | 1,254,529 | \n\n | \u00a0 | \n\n | (18,206,423 | \n) | \n
| \u00a0 | \n\u00a0 | \nGoodwill impairment testing | \n
Significant estimates used by management | \n \u00a0 | \nNGW | \n
Years of cash flows before terminal value | \n \u00a0 | \n6 | \n
Discount rate | \n \u00a0 | \n19.25% | \n
Terminal value multiple | \n \u00a0 | \n
| 8. Leases |
\u00a0
\nThe Company\u2019s lease agreements are for cultivation, manufacturing, retail, and office premises and for vehicles. The property lease terms range between 7 years and 21 years depending on the facility and are subject to an average of 2 renewal periods of equal length as the original lease. Certain leases include escalation clauses or payment of executory costs such as property taxes, utilities, or insurance and maintenance. Rent expense for leases with escalation clauses is accounted for on a straight-line basis over the lease term. The Company\u2019s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
\n\u00a0
\nThe following table provides the components of lease cost recognized in the consolidated statement of operations and comprehensive loss for 2022 and 2021:
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Operating lease costs | \u00a0 | $ | 4,584,550 | \u00a0 | $ | 4,437,816 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Finance lease costs: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Amortization of lease assets | \u00a0 | - | \u00a0 | 44,672 | ||||
Interest on lease liabilities | \u00a0 | - | \u00a0 | 3,431 | ||||
Finance lease costs | \u00a0 | - | \u00a0 | 48,103 | ||||
Short term lease expense | \u00a0 | 12,406 | \u00a0 | 19,917 | ||||
Total lease costs | \u00a0 | $ | 4,596,956 | \u00a0 | $ | 4,505,836 |
\u00a0
\nOther information related to operating and finance leases as of and for the year end December 31, 2022 and 2021 are as follows:
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | December 31, 2021 | ||||||||||||
| \u00a0 | \u00a0 | Finance | \u00a0 | Operating | \u00a0 | Finance | \u00a0 | Operating | ||||||||
| \u00a0 | \u00a0 | Lease | \u00a0 | Lease | \u00a0 | Lease | \u00a0 | Lease | ||||||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Weighted average discount rate | \u00a0 | 15.00 | % | \u00a0 | 15.00 | % | \u00a0 | 15.00 | % | \u00a0 | 15.00 | % | ||||
Weighted average remaining lease term | \u00a0 | - | \u00a0 | 14.43 | \u00a0 | - | \u00a0 | 11.87 |
\u00a0
\n \n \nThe maturity of the contractual undiscounted lease liabilities as of December 31, 2022 and 2021 is:
\n\u00a0
\n \n| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | Operating | \u00a0 | Operating | ||||
| \u00a0 | \u00a0 | Lease | \u00a0 | Lease | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
2022 | \u00a0 | $ | - | \u00a0 | $ | 3,595,030 | ||
2023 | \u00a0 | 4,052,167 | \u00a0 | 3,729,936 | ||||
2024 | \u00a0 | 4,214,502 | \u00a0 | 3,870,217 | ||||
2025 | \u00a0 | 4,302,534 | \u00a0 | 3,956,923 | ||||
2026 | \u00a0 | 4,303,434 | \u00a0 | 3,880,082 | ||||
2027 | \u00a0 | 4,389,610 | \u00a0 | 3,903,423 | ||||
2028 | \u00a0 | 4,566,581 | \u00a0 | 4,054,970 | ||||
Thereafter | \u00a0 | 53,708,289 | \u00a0 | 46,179,762 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Total undiscounted lease liabilities | \u00a0 | 79,537,117 | \u00a0 | 73,170,343 | ||||
Interest on lease liabilities | \u00a0 | (53,224,885 | ) | \u00a0 | (49,612,758 | ) | ||
Total present value of minimum lease payments | \u00a0 | 26,312,232 | \u00a0 | 23,557,585 | ||||
Lease liability - current portion | \u00a0 | (479,161 | ) | \u00a0 | (423,573 | ) | ||
Lease liability | \u00a0 | $ | 25,833,071 | \u00a0 | $ | 23,134,012 |
\u00a0
\nPrincipally, all leases relate to real estate.\u00a0
\n\u00a0
\nFor the year ended December 31, 2022 the Company incurred $4,584,550 of operating lease costs (2021 - $4,437,816), of which $1,840,018\u00a0(2021 - $1,829,800) was allocated to cost of goods sold.
\n\u00a0
\nOn December 22, 2022, the Company entered into a sale-leaseback transaction with an unrelated third-party related to certain real property acquired in connection with the NGW acquisition. The Company received cash proceeds of $1,049,633 and recorded a gain on sale-leaseback of $509,392. The following are the key terms of the related lease agreement:
\n\u00a0
\n| \u00a0 | \u25cf | Initial term: 15 years |
| \u00a0 | \u25cf | Renewal options: 3 additional terms of years each |
| \u00a0 | \u25cf | Monthly payment: $7,847 |
| \u00a0 | \u25cf | Other: Triple net |
\u00a0
\nSee Note 16 for additional supplemental cash flow information related to leases.
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-729","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseTermOfContract","xbrl:period":"2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:BuildingMember","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"P7Y"}]},{"name":"rpt:f-730","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseTermOfContract","xbrl:period":"2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","us-gaap:PropertyPlantAndEquipmentByTypeAxis":"us-gaap:BuildingMember","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"P21Y"}]},{"name":"rpt:f-731","factDimensions":{"xbrl:concept":"plnhf:LesseeOperatingLeaseTermOfContractRenewalPeriods","xbrl:period":"2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"2"}]},{"name":"rpt:f-732","factDimensions":{"xbrl:concept":"us-gaap:LeaseCostTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Operating lease costs | \u00a0 | $ | 4,584,550 | \u00a0 | $ | 4,437,816 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Finance lease costs: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Amortization of lease assets | \u00a0 | - | \u00a0 | 44,672 | ||||
Interest on lease liabilities | \u00a0 | - | \u00a0 | 3,431 | ||||
Finance lease costs | \u00a0 | - | \u00a0 | 48,103 | ||||
Short term lease expense | \u00a0 | 12,406 | \u00a0 | 19,917 | ||||
Total lease costs | \u00a0 | $ | 4,596,956 | \u00a0 | $ | 4,505,836 |
| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | December 31, 2021 | ||||||||||||
| \u00a0 | \u00a0 | Finance | \u00a0 | Operating | \u00a0 | Finance | \u00a0 | Operating | ||||||||
| \u00a0 | \u00a0 | Lease | \u00a0 | Lease | \u00a0 | Lease | \u00a0 | Lease | ||||||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Weighted average discount rate | \u00a0 | 15.00 | % | \u00a0 | 15.00 | % | \u00a0 | 15.00 | % | \u00a0 | 15.00 | % | ||||
Weighted average remaining lease term | \u00a0 | - | \u00a0 | 14.43 | \u00a0 | - | \u00a0 | 11.87 |
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | Operating | \u00a0 | Operating | ||||
| \u00a0 | \u00a0 | Lease | \u00a0 | Lease | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
2022 | \u00a0 | $ | - | \u00a0 | $ | 3,595,030 | ||
2023 | \u00a0 | 4,052,167 | \u00a0 | 3,729,936 | ||||
2024 | \u00a0 | 4,214,502 | \u00a0 | 3,870,217 | ||||
2025 | \u00a0 | 4,302,534 | \u00a0 | 3,956,923 | ||||
2026 | \u00a0 | 4,303,434 | \u00a0 | 3,880,082 | ||||
2027 | \u00a0 | 4,389,610 | \u00a0 | 3,903,423 | ||||
2028 | \u00a0 | 4,566,581 | \u00a0 | 4,054,970 | ||||
Thereafter | \u00a0 | 53,708,289 | \u00a0 | 46,179,762 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Total undiscounted lease liabilities | \u00a0 | 79,537,117 | \u00a0 | 73,170,343 | ||||
Interest on lease liabilities | \u00a0 | (53,224,885 | ) | \u00a0 | (49,612,758 | ) | ||
Total present value of minimum lease payments | \u00a0 | 26,312,232 | \u00a0 | 23,557,585 | ||||
Lease liability - current portion | \u00a0 | (479,161 | ) | \u00a0 | (423,573 | ) | ||
Lease liability | \u00a0 | $ | 25,833,071 | \u00a0 | $ | 23,134,012 |
| 9. Notes payable |
\u00a0
\nNon-related parties
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Promissory note dated November 4, 2015, with semi-annual interest at %, secured by deed of trust, due December 1, 2019 | \u00a0 | 884,000 | \u00a0 | 884,000 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | $ | 884,000 | \u00a0 | $ | 884,000 | ||
Less current portion | \u00a0 | (884,000 | ) | \u00a0 | (884,000 | ) | ||
| \u00a0 | \u00a0 | $ | - | \u00a0 | $ | - | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Stated maturities of debt obligations are as follow: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Next 12 months Promissory Note | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | $ | 884,000 |
| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Promissory note dated November 4, 2015, with semi-annual interest at %, secured by deed of trust, due December 1, 2019 | \u00a0 | 884,000 | \u00a0 | 884,000 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | $ | 884,000 | \u00a0 | $ | 884,000 | ||
Less current portion | \u00a0 | (884,000 | ) | \u00a0 | (884,000 | ) | ||
| \u00a0 | \u00a0 | $ | - | \u00a0 | $ | - | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Stated maturities of debt obligations are as follow: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Next 12 months Promissory Note | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | $ | 884,000 |
| 10. Share capital |
\u00a0
\nThe Company is authorized to issue an unlimited number of common shares and an unlimited number of Class A shares.
\n\u00a0
\n \n| \u00a0 | \u00a0 | \u00a0 | Number of Common Shares | ||||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
Common Shares | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Balance at January 1 | \u00a0 | 198,687,950 | \u00a0 | 126,573,250 | |||||
Shares issued on settlement of RSUs | i. | \u00a0 | 81,084 | \u00a0 | 3,126,534 | ||||
Shares issued on exercise of options | ii. | \u00a0 | 97,325 | \u00a0 | 121,336 | ||||
Shares issued on exercise of warrants | iii. | \u00a0 | 242,700 | \u00a0 | 3,772,640 | ||||
Shares issued on financing - February 2021 | iv. | \u00a0 | - | \u00a0 | 9,861,250 | ||||
Shares issued on conversion of Class A shares | v. | \u00a0 | - | \u00a0 | 55,232,940 | ||||
Shares issued on acquisition (Note 7) | \u00a0 | 21,361,002 | \u00a0 | - | |||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Total common shares outstanding on December 31 | \u00a0 | 220,470,061 | \u00a0 | 198,687,950 |
\u00a0
\ni. Shares issued for Restricted Share Units
\n\u00a0
\nDuring the year ended December 31, 2022, the Company issued 81,084 common shares on the settlement of RSUs\u00a0that had vested during the year. The Company did not receive any cash proceeds on the settlement.
\n\u00a0
\nDuring the year ended December 31, 2021, the Company issued 3,126,534 common shares on the settlement of RSUs\u00a0that had vested during the year. The Company did not receive any cash proceeds on the settlement.
\n\u00a0
\nii. Shares issued for Stock Options
\n\u00a0
\nDuring the year ended December 31, 2022, the Company issued 97,325 common shares on the exercise of options that had a strike price of \u00a0per common share resulting in cash proceeds of $97,980 ().
\n\u00a0
\nDuring the year ended December 31, 2021, the Company issued 121,336 common shares on the exercise of options that had a strike price in the range of to per common share resulting in cash proceeds of $86,216 ().
\n\u00a0
\n \n \niii. Shares issued on the exercise of Warrants
\n\u00a0
\nDuring the year ended December 31, 2022, the Company issued 242,700 common shares to warrant holders who exercised 242,700 warrants resulting in cash proceeds of $1,044,258 ().
\n\u00a0
\nDuring the year ended December 31, 2021, the Company issued 3,772,640 common shares to warrant holders who exercised 3,772,640 warrants resulting in cash proceeds of $14,093,793 ().
\n\u00a0
\niv. Shares issued on Financing \u2013 February 2021
\n\u00a0
\nOn February 2, 2021, the Company completed a bought deal financing for aggregate gross proceeds of $53,852,980 () at a price of per unit. The Company issued 9,861,250 units of the Company. Each unit was comprised of one common share in the capital of the Company and -half of one Common Share purchase warrant. Each whole warrant entitles the holder to acquire one common share at an exercise price of per common share for a period of 24 months.
\n\u00a0
\nThe Company also issued 591,676 broker warrants that entitle the holder to purchase one common share for a period of 24 months from the closing of the offering at a price of per common share. The broker warrants were measured based on the fair market value of the warrants using a Black Scholes valuation model.
\n\u00a0
\nThe Company incurred $3,494,930 in cash share issuance costs and $1,296,170 in broker warrant costs. The warrants are initially measured at fair value (Note 11) with residual proceeds being allocated to the common shares. Issuance costs have been allocated in the same proportion, with costs allocated to the warrant liability being expensed as incurred. The net proceeds were allocated as follows:
\n\u00a0
\n \n| \u00a0 | \u00a0 | Gross Proceeds | \u00a0 | Issuance Costs | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
February 2, 2021 Financing | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Common shares (APIC) | \u00a0 | $ | 50,967,999 | \u00a0 | $ | (4,534,434 | ) | |
Warrant liability (Note 11) | \u00a0 | 2,884,981 | \u00a0 | (256,666 | ) | |||
Total | \u00a0 | $ | 53,852,980 | \u00a0 | $ | (4,791,100 | ) |
\u00a0
\nv. Shares issued on conversion of Class A Shares
\n\u00a0
\nThe Class A restricted shares have equal ratable rights as the Company\u2019s common shares to dividends, all of the Company\u2019s assets that are available for distribution upon liquidation, dissolution or winding up of the Company\u2019s affairs, do not have pre-emptive rights, are entitled to receive notice and attend shareholders meetings and to exercise one vote for each Class A share held at all meetings of shareholders of the Company other than with respect to the vote for the election or removal of directors. Each Class A shareholder is able to convert each outstanding Class A share at the option of the holder thereof into one common share at any time provided that such conversion would not cause the Company to become a US Domestic Issuer. The restriction on conversion of Class A shares are designed to prevent the Company from becoming a US Domestic Issuer. Generally, a company will be considered to be a US Domestic Issuer if:
\n\u00a0
\n(A) 50% or more of the holders of a company\u2019s common voting shares are U.S. Persons; and either (B) (i) the majority of the executive officers or directors of the Issuer are United States citizens or residents; (ii) the company has 50% or more of its assets located in the United States; or (iii) the business of the company is principally administered in the United States.
\n\u00a0
\nDuring fiscal 2021, the Company failed the foreign private issuer (\u201cFPI\u201d) test and became a US domestic issuer effective January 1, 2022.
\n\u00a0
\nOn May 6, 2021, the Company issued 55,232,940 common shares on the conversion of 55,232,940 Class A Shares.\u00a0 As of December 31, 2022, there were no longer any Class A Shares outstanding.\u00a0
\n\u00a0
\n \n \n \n| \u00a0 | \u00a0 | Number of Class A Shares | ||||||
| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
Class A Shares | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Balance at January 1 | \u00a0 | - | \u00a0 | 55,232,940 | ||||
Conversion of Class A Shares to Common | \u00a0 | - | \u00a0 | (55,232,940 | ) | |||
Total Class A Shares Outstanding | \u00a0 | - | \u00a0 | - |
| \u00a0 | \u00a0 | \u00a0 | Number of Common Shares | ||||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
Common Shares | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Balance at January 1 | \u00a0 | 198,687,950 | \u00a0 | 126,573,250 | |||||
Shares issued on settlement of RSUs | i. | \u00a0 | 81,084 | \u00a0 | 3,126,534 | ||||
Shares issued on exercise of options | ii. | \u00a0 | 97,325 | \u00a0 | 121,336 | ||||
Shares issued on exercise of warrants | iii. | \u00a0 | 242,700 | \u00a0 | 3,772,640 | ||||
Shares issued on financing - February 2021 | iv. | \u00a0 | - | \u00a0 | 9,861,250 | ||||
Shares issued on conversion of Class A shares | v. | \u00a0 | - | \u00a0 | 55,232,940 | ||||
Shares issued on acquisition (Note 7) | \u00a0 | 21,361,002 | \u00a0 | - | |||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Total common shares outstanding on December 31 | \u00a0 | 220,470,061 | \u00a0 | 198,687,950 |
| \u00a0 | \u00a0 | Gross Proceeds | \u00a0 | Issuance Costs | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
February 2, 2021 Financing | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Common shares (APIC) | \u00a0 | $ | 50,967,999 | \u00a0 | $ | (4,534,434 | ) | |
Warrant liability (Note 11) | \u00a0 | 2,884,981 | \u00a0 | (256,666 | ) | |||
Total | \u00a0 | $ | 53,852,980 | \u00a0 | $ | (4,791,100 | ) |
| \u00a0 | \u00a0 | Number of Class A Shares | ||||||
| \u00a0 | \u00a0 | December 31, | \u00a0 | December 31, | ||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
Class A Shares | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Balance at January 1 | \u00a0 | - | \u00a0 | 55,232,940 | ||||
Conversion of Class A Shares to Common | \u00a0 | - | \u00a0 | (55,232,940 | ) | |||
Total Class A Shares Outstanding | \u00a0 | - | \u00a0 | - |
| 11. Warrants |
\u00a0
\nThe following table summarizes the fair value of the warrant liability at December 31, 2022 and 2021:
\n\u00a0
\n \n| \u00a0 | \u00a0 | 2022 | \u00a0 | \u00a0 | 2021 | \u00a0 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Opening balance as at January 1 | \u00a0 | $ | 7,206,049 | \u00a0 | \u00a0 | $ | 13,204,211 | \u00a0 |
| Additions | \u00a0 | \u00a0 | - | \u00a0 | \u00a0 | \u00a0 | 2,884,981 | \u00a0 |
| Exercises | \u00a0 | \u00a0 | - | \u00a0 | \u00a0 | \u00a0 | (8,976,258 | ) |
| Foreign exchange | \u00a0 | \u00a0 | (10,117 | ) | \u00a0 | \u00a0 | 100,635 | \u00a0 |
| Change in fair value | \u00a0 | \u00a0 | (7,177,805 | ) | \u00a0 | \u00a0 | (7,520 | ) |
| Closing balance as at December 31 | \u00a0 | $ | 18,127 | \u00a0 | \u00a0 | $ | 7,206,049 | \u00a0 |
\u00a0
\nThe warrant liability is adjusted to fair value on the date the warrants are exercised and at the end of each reporting period.\u00a0 The amount that is reclassified to equity on the date of exercise is the fair value at that date.
\n\u00a0
\nThe following table summarizes the number of warrants outstanding at December 31, 2022 and 2021:
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | \u00a0 | Weighted Average Exercise Price - CAD | \u00a0 | \u00a0 | December 31, 2021 | \u00a0 | \u00a0 | Weighted Average Exercise Price - CAD | \u00a0 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Balance - beginning of year | \u00a0 | \u00a0 | 8,861,951 | \u00a0 | \u00a0 | $ | 7.46 | \u00a0 | \u00a0 | \u00a0 | 7,158,337 | \u00a0 | \u00a0 | $ | 4.98 | \u00a0 |
| Issued | \u00a0 | \u00a0 | - | \u00a0 | \u00a0 | $ | - | \u00a0 | \u00a0 | \u00a0 | 5,522,301 | \u00a0 | \u00a0 | $ | 8.79 | \u00a0 |
| Exercised | \u00a0 | \u00a0 | (242,700 | ) | \u00a0 | $ | 5.80 | \u00a0 | \u00a0 | \u00a0 | (3,772,640 | ) | \u00a0 | $ | 4.73 | \u00a0 |
| Expired | \u00a0 | \u00a0 | (3,412,788 | ) | \u00a0 | $ | 5.41 | \u00a0 | \u00a0 | \u00a0 | (46,047 | ) | \u00a0 | $ | 3.75 | \u00a0 |
| Balance - end of year | \u00a0 | \u00a0 | 5,206,463 | \u00a0 | \u00a0 | $ | 8.88 | \u00a0 | \u00a0 | \u00a0 | 8,861,951 | \u00a0 | \u00a0 | $ | 7.46 | \u00a0 |
\u00a0
\nFair values
\n\u00a0
\nThe Company complies with ASC 820, Fair Value Measurement, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. Financial instruments recorded at fair value in the consolidated balance sheet are classified using a fair value hierarchy that reflects the observability of significant inputs used in making the measurements.\u00a0
\n\u00a0
\n \n \nThe following tables present information about the Company\u2019s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022 and 2021:
\n\u00a0
\n \n| \u00a0 | \u00a0 | Quoted prices in active markets for identical asset (Level 1) | \u00a0 | Significant unobservable inputs (Level 3) | \u00a0 | Total | ||||||
December 31, 2022 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Warrant liability | \u00a0 | $ | (18,127 | ) | \u00a0 | $ | - | \u00a0 | $ | (18,127 | ) | |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
December 31, 2021 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Warrant liability | \u00a0 | $ | (7,206,049 | ) | \u00a0 | $ | - | \u00a0 | $ | (7,206,049 | ) |
| \u00a0 | \u00a0 | 2022 | \u00a0 | \u00a0 | 2021 | \u00a0 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Opening balance as at January 1 | \u00a0 | $ | 7,206,049 | \u00a0 | \u00a0 | $ | 13,204,211 | \u00a0 |
| Additions | \u00a0 | \u00a0 | - | \u00a0 | \u00a0 | \u00a0 | 2,884,981 | \u00a0 |
| Exercises | \u00a0 | \u00a0 | - | \u00a0 | \u00a0 | \u00a0 | (8,976,258 | ) |
| Foreign exchange | \u00a0 | \u00a0 | (10,117 | ) | \u00a0 | \u00a0 | 100,635 | \u00a0 |
| Change in fair value | \u00a0 | \u00a0 | (7,177,805 | ) | \u00a0 | \u00a0 | (7,520 | ) |
| Closing balance as at December 31 | \u00a0 | $ | 18,127 | \u00a0 | \u00a0 | $ | 7,206,049 | \u00a0 |
| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | \u00a0 | Weighted Average Exercise Price - CAD | \u00a0 | \u00a0 | December 31, 2021 | \u00a0 | \u00a0 | Weighted Average Exercise Price - CAD | \u00a0 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| Balance - beginning of year | \u00a0 | \u00a0 | 8,861,951 | \u00a0 | \u00a0 | $ | 7.46 | \u00a0 | \u00a0 | \u00a0 | 7,158,337 | \u00a0 | \u00a0 | $ | 4.98 | \u00a0 |
| Issued | \u00a0 | \u00a0 | - | \u00a0 | \u00a0 | $ | - | \u00a0 | \u00a0 | \u00a0 | 5,522,301 | \u00a0 | \u00a0 | $ | 8.79 | \u00a0 |
| Exercised | \u00a0 | \u00a0 | (242,700 | ) | \u00a0 | $ | 5.80 | \u00a0 | \u00a0 | \u00a0 | (3,772,640 | ) | \u00a0 | $ | 4.73 | \u00a0 |
| Expired | \u00a0 | \u00a0 | (3,412,788 | ) | \u00a0 | $ | 5.41 | \u00a0 | \u00a0 | \u00a0 | (46,047 | ) | \u00a0 | $ | 3.75 | \u00a0 |
| Balance - end of year | \u00a0 | \u00a0 | 5,206,463 | \u00a0 | \u00a0 | $ | 8.88 | \u00a0 | \u00a0 | \u00a0 | 8,861,951 | \u00a0 | \u00a0 | $ | 7.46 | \u00a0 |
| \u00a0 | \u00a0 | Quoted prices in active markets for identical asset (Level 1) | \u00a0 | Significant unobservable inputs (Level 3) | \u00a0 | Total | ||||||
December 31, 2022 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Warrant liability | \u00a0 | $ | (18,127 | ) | \u00a0 | $ | - | \u00a0 | $ | (18,127 | ) | |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
December 31, 2021 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Warrant liability | \u00a0 | $ | (7,206,049 | ) | \u00a0 | $ | - | \u00a0 | $ | (7,206,049 | ) |
| 12. Share based compensation | \n
\u00a0
\n(a) Stock options
\n\u00a0
\nThe Company has established an incentive stock option plan (the \u201cPlan\u201d) for employees, management, directors, and consultants of the Company, as designated and administered by a committee of the Company\u2019s Board of Directors. Under the Plan, the Company may grant options for up to 10% of the issued and outstanding common shares of the Company.\u00a0The maximum term of an option is years and the related vesting period runs from immediate to the life of the grant.
\n\u00a0
\nDuring the years ended December 31, 2022 and 2021
\n\u00a0
\nNo incentive stock options were granted during the years ended December 31, 2022 and 2021, and 1,106,925 replacement options were issued in connection with the NGW acquisition (see Note 7). The replacement options were fully vested upon issuance.
\n\u00a0
\nThe following table summarizes information about stock options outstanding at December 31, 2022 and 2021:\u00a0
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \nExercise price | \n \n | \u00a0 | \nDecember 31, 2022 | \n \n | \u00a0 | \nDecember 31, 2022 | \n \n | \u00a0 | \nDecember 31, 2021 | \n \n | \u00a0 | \nDecember 31, 2021 | \n \n | |||||
Expiry Date | \n \u00a0 | \n\n | CAD$ | \n\n | \u00a0 | \nOutstanding | \n \n | \u00a0 | \nExercisable | \n \n | \u00a0 | \nOutstanding | \n \n | \u00a0 | \nExercisable | \n \n | ||||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
November 21, 2024 | \n \u00a0 | \n$ | \n1.31 | \n\n | \u00a0 | \n\n | 185,203 | \n\n | \u00a0 | \n\n | 185,203 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
February 27, 2025 | \n \u00a0 | \n$ | \n1.31 | \n\n | \u00a0 | \n\n | 51,525 | \n\n | \u00a0 | \n\n | 51,525 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
December 15, 2025 | \n \u00a0 | \n$ | \n3.06 | \n\n | \u00a0 | \n\n | 269,075 | \n\n | \u00a0 | \n\n | 269,075 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
September 30, 2026 | \n \u00a0 | \n$ | \n4.37 | \n\n | \u00a0 | \n\n | 120,222 | \n\n | \u00a0 | \n\n | 120,222 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
July 6, 2025 | \n \u00a0 | \n$ | \n1.31 | \n\n | \u00a0 | \n\n | 97,325 | \n\n | \u00a0 | \n\n | 97,325 | \n\n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
July 4, 2022 | \n \u00a0 | \n$ | \n2.65 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 100,000 | \n\n | \u00a0 | \n\n | 100,000 | \n\n |
June 11, 2023 | \n \u00a0 | \n$ | \n0.80 | \n\n | \u00a0 | \n\n | 61,668 | \n\n | \u00a0 | \n\n | 61,668 | \n\n | \u00a0 | \n\n | 61,668 | \n\n | \u00a0 | \n\n | 61,668 | \n\n |
June 30, 2024 | \n \u00a0 | \n$ | \n2.60 | \n\n | \u00a0 | \n\n | 7,500 | \n\n | \u00a0 | \n\n | 7,500 | \n\n | \u00a0 | \n\n | 7,500 | \n\n | \u00a0 | \n\n | 7,500 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\n | 792,518 | \n\n | \u00a0 | \n\n | 792,518 | \n\n | \u00a0 | \n\n | 169,168 | \n\n | \u00a0 | \n\n | 169,168 | \n\n |
\u00a0
\n \n \nThe following assumptions were used to arrive at the value ascribed to the options issued using a Black Scholes Option Pricing model:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n December 31, | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n 2022 | \n \u00a0 | \n\u00a0 | \n 2021 | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Share price | \n \u00a0 | \n$ | \n3.34 | \n\u00a0 | \n\u00a0 | \n$ | \n- | \n\u00a0 | \n
| Risk-free rate | \n \u00a0 | \n\u00a0 | \n1.12 | \n% | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Expected dividend yield | \n \u00a0 | \n\u00a0 | \n0.00 | \n% | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Expected volatility | \n \u00a0 | \n\u00a0 | \n69.67 | \n% | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Option life in years | \n \u00a0 | \n\u00a0 | \n1.20 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
\u00a0
\nShare based compensation expense attributable to employee options was \u00a0for the year ended December 31, 2022, (2021: $3,104). The fair value of the replacement options issued during the year of $1,239,818 was recognized as part of the consideration paid related to the business combination of NGW (Note 7).
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \nDecember 31, | \n \n | |||||
| \u00a0 | \n\u00a0 | \n2022 | \n \n | \u00a0 | \n2021 | \n \n | ||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
The outstanding options have a weighted average CAD$ exercise price of: | \n \u00a0 | \n$ | \n2.34 | \n\n | \u00a0 | \n$ | \n2.01 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Weighted average remaining life in years of outstanding options: | \n \u00a0 | \n\n | 2.51 | \n\n | \u00a0 | \n\n | 0.94 | \n\n |
\u00a0
\n \n| \u00a0 | \n\u00a0 | \n December 31, 2022 | \n \u00a0 | \n\u00a0 | \n Weighted Average Exercise Price - CAD | \n \u00a0 | \n\u00a0 | \n December 31, 2021 | \n \u00a0 | \n\u00a0 | \n Weighted Average Exercise Price - CAD | \n \u00a0 | \n||||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Balance - beginning of year | \n \u00a0 | \n\u00a0 | \n169,168 | \n\u00a0 | \n\u00a0 | \n$ | \n2.01 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n293,838 | \n\u00a0 | \n\u00a0 | \n$ | \n1.52 | \n\u00a0 | \n
| Issued | \n \u00a0 | \n\u00a0 | \n1,106,925 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n2.58 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Exercised | \n \u00a0 | \n\u00a0 | \n(97,325 | \n) | \n\u00a0 | \n\u00a0 | \n1.31 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(121,336 | \n) | \n\u00a0 | \n\u00a0 | \n0.91 | \n\u00a0 | \n
| Expired | \n \u00a0 | \n\u00a0 | \n(386,250 | \n) | \n\u00a0 | \n\u00a0 | \n3.11 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(3,334 | \n) | \n\u00a0 | \n\u00a0 | \n0.80 | \n\u00a0 | \n
| Forfeited | \n \u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Balance - end of year | \n \u00a0 | \n\u00a0 | \n792,518 | \n\u00a0 | \n\u00a0 | \n$ | \n2.34 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n169,168 | \n\u00a0 | \n\u00a0 | \n$ | \n2.01 | \n\u00a0 | \n
\u00a0
\nThe total intrinsic value of stock options exercised, outstanding and exercisable as of December 31, 2022, was
\n\u00a0
\nThe total intrinsic value of stock options exercised, outstanding and exercisable as of December 31, 2021, was $274,611, $238,010 and $238,010, respectively.
\n\u00a0
\n(b) Restricted Share Units
\n\u00a0
\nThe Company has established a Restricted Share Unit incentive plan (the \u201cRSU Plan\u201d) for employees, management, directors, and consultants of the Company, as designated and administered by a committee of the Company\u2019s Board of Directors. Under the RSU Plan, the Company may grant RSUs and/or options for up to 10% of the issued and outstanding common shares of the Company.\u00a0
\n\u00a0
\n \n \nThe following table summarizes the RSUs that are outstanding as at December 31, 2022 and 2021:
\n\u00a0
\n \n| \u00a0 | \n\u00a0 | \n December 31, 2022 | \n \u00a0 | \n\u00a0 | \n December 31, 2021 | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Balance - beginning of year | \n \u00a0 | \n\u00a0 | \n2,591,929 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,764,250 | \n\u00a0 | \n
| Issued | \n \u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,086,178 | \n\u00a0 | \n
| Exercised | \n \u00a0 | \n\u00a0 | \n(81,084 | \n) | \n\u00a0 | \n\u00a0 | \n(3,126,534 | \n) | \n
| Expired | \n \u00a0 | \n\u00a0 | \n(45,917 | \n) | \n\u00a0 | \n\u00a0 | \n(131,965 | \n) | \n
| Balance - end of year | \n \u00a0 | \n\u00a0 | \n2,464,928 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n2,591,929 | \n\u00a0 | \n
\u00a0
\nThe Company recognized $7,459,267 in share-based compensation expense attributable to RSUs vesting during the year ended December 31, 2022 ($15,573,539 for the year ended December 31, 2021).
\n\u00a0
\nDuring the year ended December 31, 2022
\n\u00a0
\nNo RSUs were granted during the year ended\u00a0 December 31, 2022.
\n\u00a0
\nThe Company issued 81,084 common shares on the exercise of 81,084 RSUs during the year\u00a0ended\u00a0 December 31, 2022.
\n\u00a0
\nDuring the year\u00a0ended\u00a0 December 31, 2022, 45,917 RSUs were forfeited.
\n\u00a0
\nDuring the year ended December 31, 2021
\n\u00a0
\nOn April 19, 2021, the Company granted 4,082,474 RSUs to officers, directors, and employees pursuant to the Company\u2019s RSU Plan.\u00a0 The RSUs granted vest in three equal tranches on November 1, 2021, November 1, 2022, and November 1, 2023, unless otherwise varied pursuant to the terms of the plan.\u00a0 The value ascribed to the RSUs issued was
\n\u00a0
\nOn June 10, 2021, the Company granted 3,704 RSUs to a consultant of the Company pursuant to the Company\u2019s RSU Plan.\u00a0 The value ascribed to the RSUs issued was \u00a0 The RSUs vested immediately and were exercised on June 10, 2021.
\n\u00a0
\nThe Company issued 3,126,534 common shares on the exercise of 3,126,534 RSUs during the year ended December 31, 2021.
\n "}]},{"name":"rpt:f-898","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember","us-gaap:PlanNameAxis":"plnhf:ThePlanMember"},"factValues":[{"value":"0.10","decimals":1}]},{"name":"rpt:f-899","factDimensions":{"xbrl:concept":"us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"xbrla:shares","us-gaap:PlanNameAxis":"plnhf:ThePlanMember"},"factValues":[{"value":"0","decimals":-3}]},{"name":"rpt:f-900","factDimensions":{"xbrl:concept":"us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued","xbrl:period":"2022-03-02T00:00:00/2022-03-03T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"xbrla:shares","us-gaap:AwardTypeAxis":"us-gaap:EmployeeStockOptionMember","us-gaap:BusinessAcquisitionAxis":"plnhf:NextGreenWaveHoldingsIncngwMember"},"factValues":[{"value":"1106925"}]},{"name":"rpt:f-901","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \nExercise price | \n \n | \u00a0 | \nDecember 31, 2022 | \n \n | \u00a0 | \nDecember 31, 2022 | \n \n | \u00a0 | \nDecember 31, 2021 | \n \n | \u00a0 | \nDecember 31, 2021 | \n \n | |||||
Expiry Date | \n \u00a0 | \n\n | CAD$ | \n\n | \u00a0 | \nOutstanding | \n \n | \u00a0 | \nExercisable | \n \n | \u00a0 | \nOutstanding | \n \n | \u00a0 | \nExercisable | \n \n | ||||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
November 21, 2024 | \n \u00a0 | \n$ | \n1.31 | \n\n | \u00a0 | \n\n | 185,203 | \n\n | \u00a0 | \n\n | 185,203 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
February 27, 2025 | \n \u00a0 | \n$ | \n1.31 | \n\n | \u00a0 | \n\n | 51,525 | \n\n | \u00a0 | \n\n | 51,525 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
December 15, 2025 | \n \u00a0 | \n$ | \n3.06 | \n\n | \u00a0 | \n\n | 269,075 | \n\n | \u00a0 | \n\n | 269,075 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
September 30, 2026 | \n \u00a0 | \n$ | \n4.37 | \n\n | \u00a0 | \n\n | 120,222 | \n\n | \u00a0 | \n\n | 120,222 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n |
July 6, 2025 | \n \u00a0 | \n$ | \n1.31 | \n\n | \u00a0 | \n\n | 97,325 | \n\n | \u00a0 | \n\n | 97,325 | \n\n | \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
July 4, 2022 | \n \u00a0 | \n$ | \n2.65 | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | - | \n\n | \u00a0 | \n\n | 100,000 | \n\n | \u00a0 | \n\n | 100,000 | \n\n |
June 11, 2023 | \n \u00a0 | \n$ | \n0.80 | \n\n | \u00a0 | \n\n | 61,668 | \n\n | \u00a0 | \n\n | 61,668 | \n\n | \u00a0 | \n\n | 61,668 | \n\n | \u00a0 | \n\n | 61,668 | \n\n |
June 30, 2024 | \n \u00a0 | \n$ | \n2.60 | \n\n | \u00a0 | \n\n | 7,500 | \n\n | \u00a0 | \n\n | 7,500 | \n\n | \u00a0 | \n\n | 7,500 | \n\n | \u00a0 | \n\n | 7,500 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\n | 792,518 | \n\n | \u00a0 | \n\n | 792,518 | \n\n | \u00a0 | \n\n | 169,168 | \n\n | \u00a0 | \n\n | 169,168 | \n\n |
| \u00a0 | \n\u00a0 | \n December 31, | \n \u00a0 | \n|||||
| \u00a0 | \n\u00a0 | \n 2022 | \n \u00a0 | \n\u00a0 | \n 2021 | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Share price | \n \u00a0 | \n$ | \n3.34 | \n\u00a0 | \n\u00a0 | \n$ | \n- | \n\u00a0 | \n
| Risk-free rate | \n \u00a0 | \n\u00a0 | \n1.12 | \n% | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Expected dividend yield | \n \u00a0 | \n\u00a0 | \n0.00 | \n% | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Expected volatility | \n \u00a0 | \n\u00a0 | \n69.67 | \n% | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Option life in years | \n \u00a0 | \n\u00a0 | \n1.20 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \nDecember 31, | \n \n | |||||
| \u00a0 | \n\u00a0 | \n2022 | \n \n | \u00a0 | \n2021 | \n \n | ||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
The outstanding options have a weighted average CAD$ exercise price of: | \n \u00a0 | \n$ | \n2.34 | \n\n | \u00a0 | \n$ | \n2.01 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Weighted average remaining life in years of outstanding options: | \n \u00a0 | \n\n | 2.51 | \n\n | \u00a0 | \n\n | 0.94 | \n\n |
| \u00a0 | \n\u00a0 | \n December 31, 2022 | \n \u00a0 | \n\u00a0 | \n Weighted Average Exercise Price - CAD | \n \u00a0 | \n\u00a0 | \n December 31, 2021 | \n \u00a0 | \n\u00a0 | \n Weighted Average Exercise Price - CAD | \n \u00a0 | \n||||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Balance - beginning of year | \n \u00a0 | \n\u00a0 | \n169,168 | \n\u00a0 | \n\u00a0 | \n$ | \n2.01 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n293,838 | \n\u00a0 | \n\u00a0 | \n$ | \n1.52 | \n\u00a0 | \n
| Issued | \n \u00a0 | \n\u00a0 | \n1,106,925 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n2.58 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Exercised | \n \u00a0 | \n\u00a0 | \n(97,325 | \n) | \n\u00a0 | \n\u00a0 | \n1.31 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(121,336 | \n) | \n\u00a0 | \n\u00a0 | \n0.91 | \n\u00a0 | \n
| Expired | \n \u00a0 | \n\u00a0 | \n(386,250 | \n) | \n\u00a0 | \n\u00a0 | \n3.11 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n(3,334 | \n) | \n\u00a0 | \n\u00a0 | \n0.80 | \n\u00a0 | \n
| Forfeited | \n \u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n
| Balance - end of year | \n \u00a0 | \n\u00a0 | \n792,518 | \n\u00a0 | \n\u00a0 | \n$ | \n2.34 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n169,168 | \n\u00a0 | \n\u00a0 | \n$ | \n2.01 | \n\u00a0 | \n
| \u00a0 | \n\u00a0 | \n December 31, 2022 | \n \u00a0 | \n\u00a0 | \n December 31, 2021 | \n \u00a0 | \n||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
| Balance - beginning of year | \n \u00a0 | \n\u00a0 | \n2,591,929 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n1,764,250 | \n\u00a0 | \n
| Issued | \n \u00a0 | \n\u00a0 | \n- | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n4,086,178 | \n\u00a0 | \n
| Exercised | \n \u00a0 | \n\u00a0 | \n(81,084 | \n) | \n\u00a0 | \n\u00a0 | \n(3,126,534 | \n) | \n
| Expired | \n \u00a0 | \n\u00a0 | \n(45,917 | \n) | \n\u00a0 | \n\u00a0 | \n(131,965 | \n) | \n
| Balance - end of year | \n \u00a0 | \n\u00a0 | \n2,464,928 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n2,591,929 | \n\u00a0 | \n
| 13. Loss per share | \n
\u00a0
\n \n| \u00a0 | \n\u00a0 | \nDecember 31, 2022 | \n \n | \u00a0 | \nDecember 31, 2021 | \n \n | ||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Loss available to common shareholders | \n \u00a0 | \n$ | \n(48,980,300 | \n) | \n\u00a0 | \n$ | \n(19,460,953 | \n) | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Weighted average number of shares outstanding, basic and diluted | \n \u00a0 | \n\n | 216,586,621 | \n\n | \u00a0 | \n\n | 195,126,972 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Basic and diluted loss per share | \n \u00a0 | \n$ | \n(0.23 | \n) | \n\u00a0 | \n$ | \n(0.10 | \n) | \n
\u00a0
\nApproximately 8,463,909 and 11,623,051 of potentially dilutive securities for the years ended December 31, 2022\u00a0and\u00a0 December 31, 2021 respectively were excluded in the calculation of diluted EPS as their impact would have been anti-dilutive due to net loss in such years.
\n\u00a0
\n \n \n "}]},{"name":"rpt:f-1011","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| \u00a0 | \n\u00a0 | \nDecember 31, 2022 | \n \n | \u00a0 | \nDecember 31, 2021 | \n \n | ||
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Loss available to common shareholders | \n \u00a0 | \n$ | \n(48,980,300 | \n) | \n\u00a0 | \n$ | \n(19,460,953 | \n) | \n
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Weighted average number of shares outstanding, basic and diluted | \n \u00a0 | \n\n | 216,586,621 | \n\n | \u00a0 | \n\n | 195,126,972 | \n\n |
| \u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n\u00a0 | \n
Basic and diluted loss per share | \n \u00a0 | \n$ | \n(0.23 | \n) | \n\u00a0 | \n$ | \n(0.10 | \n) | \n
| 14. Income taxes |
\u00a0
\nThe components of income tax expense (benefit) of the Company are summarized as follows:
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | December 31, 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Current tax expense (recovery) | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Current period | \u00a0 | $ | 10,672,538 | \u00a0 | $ | 13,954,784 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Deferred tax expense (recovery) | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Origination and reversal of timing differences | \u00a0 | (5,492,926 | ) | \u00a0 | (4,376,359 | ) | ||
Change in unrecognized temporary differences | \u00a0 | 3,572,749 | \u00a0 | 3,900,133 | ||||
| \u00a0 | \u00a0 | $ | 8,752,361 | \u00a0 | $ | 13,478,558 |
\u00a0
\nThe actual income tax provision differs from the expected amount calculated by applying the statutory income tax rate to the loss before tax. These differences result from the following:
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | December 31, 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Loss before income tax | \u00a0 | $ | (40,227,939 | ) | \u00a0 | $ | (5,982,394 | ) |
Statutory income tax rate | \u00a0 | 21.0 | % | \u00a0 | 21.0 | % | ||
Income tax expense at statutory rate | \u00a0 | (8,447,867 | ) | \u00a0 | (1,256,303 | ) | ||
Increase (reduction) in income taxes resulting from: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Change in fair value of warrant liability | \u00a0 | (1,507,339 | ) | \u00a0 | (1,579 | ) | ||
Other non-taxable amounts | \u00a0 | 14,542,266 | \u00a0 | 12,019,720 | ||||
Change in valuation allowance | \u00a0 | 3,572,749 | \u00a0 | 3,900,133 | ||||
Difference in rates | \u00a0 | (362,832 | ) | \u00a0 | (1,159,859 | ) | ||
Other | \u00a0 | 955,384 | \u00a0 | (23,554 | ) | |||
Income tax expense (benefit) | \u00a0 | $ | 8,752,361 | \u00a0 | $ | 13,478,558 |
\u00a0
\nSection 280E prohibits businesses engaged in the trafficking of Schedule I or Schedule II controlled substances from deducting normal business expenses, such as payroll and rent, from gross income (revenue less cost of goods sold). Section 280E was originally intended to penalize criminal market operators, but because cannabis remains a Schedule I controlled substance for Federal purposes, the Internal Revenue Service (\u201cIRS\u201d) has subsequently applied Section 280E to state-legal cannabis businesses. Cannabis businesses operating in states that align their tax codes with the IRC are also unable to deduct normal business expenses from taxable income subject to state taxes. The non-taxable amounts shown in the effective rate reconciliation above include the impact of applying IRC Section 280E to the Company's businesses that are involved in selling cannabis, along with other typical non-deductible expenses. As the application and IRS interpretations on Section 280E continue to evolve, the impact of this cannot be reliably estimated. Any changes to the application of Section 280E may have a material effect on the Company\u2019s consolidated financial statements.
\n\u00a0
\n \n \nDeferred tax assets and liabilities have been offset where they relate to income taxes levied by the same taxation authority and the Company has the legal right and intent to offset. Deferred tax assets (liabilities) are attributable to the following:
\n\u00a0
\n \n| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | December 31, 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Loss carryforwards | \u00a0 | $ | 11,769,754 | \u00a0 | $ | 9,094,791 | ||
Share issue costs | \u00a0 | 834,063 | \u00a0 | 1,489,956 | ||||
Stock compensation | \u00a0 | 2,203,368 | \u00a0 | 657,647 | ||||
Exchange rate difference on monetary assets | \u00a0 | 709,938 | \u00a0 | 715,299 | ||||
Accrued expenses | \u00a0 | 343,416 | \u00a0 | 139,999 | ||||
Property and equipment | \u00a0 | (1,842,051 | ) | \u00a0 | (1,578,803 | ) | ||
Licenses | \u00a0 | (1,774,379 | ) | \u00a0 | (543,779 | ) | ||
Deferred tax assets (liabilities) | \u00a0 | 12,244,109 | \u00a0 | 9,975,111 | ||||
Valuation allowance | \u00a0 | (13,385,056 | ) | \u00a0 | (9,812,307 | ) | ||
Net deferred tax liability | \u00a0 | $ | (1,140,947 | ) | \u00a0 | $ | 162,804 |
\u00a0
\nAs at December 31, 2022, the Company has $29,518,011 ( December 31, 2021 - $19,139,273) in Canadian non-capital loss carryforwards that expire between 2037\u00a0and 2042.\u00a0 In addition, as at December 31, 2022, the Company has U.S. federal Net Operating Losses of\u00a0$60,454,476 ( December 31, 2021 - $49,079,058). The US federal Net Operating Losses attributable to 2020\u00a0onward will have an indefinite carry forward. As at December 31, 2022, the Company has California State Net Operating Losses of $10,626,327 ( December 31, 2021 - $6,529,220). The California state Net Operating Losses will expire in 2040.
\n\u00a0
\nIn March 2020, the U.S. enacted the Coronavirus Aid, Relief, and Economic Security Act (the \u201cAct\u201d). The Act, among other provisions, reinstates the ability of corporations to carry net operating losses back to the five preceding tax years, has increased the excess interest limitation on modified taxable income from 30 percent to 50 percent. The Company has made a reasonable estimate of the effects on existing deferred tax balances and has concluded that the Act has not had a significant effect on the deferred tax balances.
\n\u00a0
\nThe Company believes that, pursuant to Section 7874 of the Code, even though it is organized as a Canadian corporation, the Company should be treated as a U.S. domestic corporation for U.S. federal income tax purposes. Because the Company is a taxable corporation in Canada, it is likely to be subject to income taxation in both the United States and Canada on the same income, which in turn, may reduce the amount of income available for distribution to shareholders. The balance of this discussion assumes the Company is a U.S. domestic corporation for U.S. federal income tax purposes. However, no tax opinion or ruling from the Internal Revenue Service (\u201cIRS\u201d) concerning the U.S. federal income tax characterization of the Company has been obtained and none will be requested. Thus, there can be no assurance that the IRS will not challenge the characterization of the Company as a domestic corporation, or that if challenged, a U.S. court would not agree with the IRS. If the Company is not treated as a U.S. domestic corporation, then the acquisition, ownership and disposition of common shares, warrants and common shares received on the exercise of warrants may have materially different implications for Non-U.S. Holders.
\n "}]},{"name":"rpt:f-1021","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | December 31, 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Current tax expense (recovery) | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Current period | \u00a0 | $ | 10,672,538 | \u00a0 | $ | 13,954,784 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Deferred tax expense (recovery) | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Origination and reversal of timing differences | \u00a0 | (5,492,926 | ) | \u00a0 | (4,376,359 | ) | ||
Change in unrecognized temporary differences | \u00a0 | 3,572,749 | \u00a0 | 3,900,133 | ||||
| \u00a0 | \u00a0 | $ | 8,752,361 | \u00a0 | $ | 13,478,558 |
| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | December 31, 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Loss before income tax | \u00a0 | $ | (40,227,939 | ) | \u00a0 | $ | (5,982,394 | ) |
Statutory income tax rate | \u00a0 | 21.0 | % | \u00a0 | 21.0 | % | ||
Income tax expense at statutory rate | \u00a0 | (8,447,867 | ) | \u00a0 | (1,256,303 | ) | ||
Increase (reduction) in income taxes resulting from: | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Change in fair value of warrant liability | \u00a0 | (1,507,339 | ) | \u00a0 | (1,579 | ) | ||
Other non-taxable amounts | \u00a0 | 14,542,266 | \u00a0 | 12,019,720 | ||||
Change in valuation allowance | \u00a0 | 3,572,749 | \u00a0 | 3,900,133 | ||||
Difference in rates | \u00a0 | (362,832 | ) | \u00a0 | (1,159,859 | ) | ||
Other | \u00a0 | 955,384 | \u00a0 | (23,554 | ) | |||
Income tax expense (benefit) | \u00a0 | $ | 8,752,361 | \u00a0 | $ | 13,478,558 |
| \u00a0 | \u00a0 | December 31, 2022 | \u00a0 | December 31, 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Loss carryforwards | \u00a0 | $ | 11,769,754 | \u00a0 | $ | 9,094,791 | ||
Share issue costs | \u00a0 | 834,063 | \u00a0 | 1,489,956 | ||||
Stock compensation | \u00a0 | 2,203,368 | \u00a0 | 657,647 | ||||
Exchange rate difference on monetary assets | \u00a0 | 709,938 | \u00a0 | 715,299 | ||||
Accrued expenses | \u00a0 | 343,416 | \u00a0 | 139,999 | ||||
Property and equipment | \u00a0 | (1,842,051 | ) | \u00a0 | (1,578,803 | ) | ||
Licenses | \u00a0 | (1,774,379 | ) | \u00a0 | (543,779 | ) | ||
Deferred tax assets (liabilities) | \u00a0 | 12,244,109 | \u00a0 | 9,975,111 | ||||
Valuation allowance | \u00a0 | (13,385,056 | ) | \u00a0 | (9,812,307 | ) | ||
Net deferred tax liability | \u00a0 | $ | (1,140,947 | ) | \u00a0 | $ | 162,804 |
| 15. General and administrative |
\u00a0
\n \n| \u00a0 | \u00a0 | December 31, | ||||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Salaries and wages | \u00a0 | $ | 15,231,997 | \u00a0 | $ | 21,902,505 | ||
Share based compensation | \u00a0 | 7,459,267 | \u00a0 | 15,576,643 | ||||
Executive compensation | \u00a0 | 3,008,508 | \u00a0 | 2,039,174 | ||||
Licenses and permits | \u00a0 | 2,900,282 | \u00a0 | 3,217,834 | ||||
Payroll taxes and benefits | \u00a0 | 4,124,049 | \u00a0 | 3,953,034 | ||||
Supplies and office expenses | \u00a0 | 1,480,108 | \u00a0 | 3,638,097 | ||||
Subcontractors | \u00a0 | 2,589,933 | \u00a0 | 3,500,330 | ||||
Professional fees (legal, audit and other) | \u00a0 | 6,524,583 | \u00a0 | 5,015,903 | ||||
Miscellaneous general and administrative expenses | \u00a0 | 6,076,773 | \u00a0 | 1,084,836 | ||||
| \u00a0 | \u00a0 | $ | 49,395,500 | \u00a0 | $ | 59,928,356 |
\u00a0
\n \n \n "}]},{"name":"rpt:f-1077","factDimensions":{"xbrl:concept":"plnhf:ScheduleOfGeneralAndAdministrativeExpenseTableTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| \u00a0 | \u00a0 | December 31, | ||||||
| \u00a0 | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Salaries and wages | \u00a0 | $ | 15,231,997 | \u00a0 | $ | 21,902,505 | ||
Share based compensation | \u00a0 | 7,459,267 | \u00a0 | 15,576,643 | ||||
Executive compensation | \u00a0 | 3,008,508 | \u00a0 | 2,039,174 | ||||
Licenses and permits | \u00a0 | 2,900,282 | \u00a0 | 3,217,834 | ||||
Payroll taxes and benefits | \u00a0 | 4,124,049 | \u00a0 | 3,953,034 | ||||
Supplies and office expenses | \u00a0 | 1,480,108 | \u00a0 | 3,638,097 | ||||
Subcontractors | \u00a0 | 2,589,933 | \u00a0 | 3,500,330 | ||||
Professional fees (legal, audit and other) | \u00a0 | 6,524,583 | \u00a0 | 5,015,903 | ||||
Miscellaneous general and administrative expenses | \u00a0 | 6,076,773 | \u00a0 | 1,084,836 | ||||
| \u00a0 | \u00a0 | $ | 49,395,500 | \u00a0 | $ | 59,928,356 |
| 16. Supplemental cash flow information |
\u00a0
\n \n| \u00a0 | \u00a0 | December 31, | ||||||
Change in Working Capital | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
HST Receivable | \u00a0 | $ | (79,012 | ) | \u00a0 | $ | (56,787 | ) |
Accounts Receivable | \u00a0 | 1,342,487 | \u00a0 | (722,467 | ) | |||
Inventory | \u00a0 | 4,297,897 | \u00a0 | (7,305,529 | ) | |||
Prepaid Expenses and Other Assets | \u00a0 | 167,130 | \u00a0 | (1,780,041 | ) | |||
Long-term Deposits and Other Assets | \u00a0 | 199,334 | \u00a0 | (7,436 | ) | |||
Deferred Tax Assets | \u00a0 | (183,453 | ) | \u00a0 | (162,804 | ) | ||
Accounts Payable | \u00a0 | 127,789 | \u00a0 | 1,578,349 | ||||
Accrued Expenses | \u00a0 | 826,664 | \u00a0 | 4,187,906 | ||||
Income Taxes Payable | \u00a0 | 1,574,807 | \u00a0 | (319,986 | ) | |||
| \u00a0 | \u00a0 | $ | 8,273,643 | \u00a0 | $ | (4,589,077 | ) | |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Cash Paid | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Interest | \u00a0 | $ | 3,720,587 | \u00a0 | $ | 4,485,447 | ||
Income Taxes | \u00a0 | $ | 7,925,000 | \u00a0 | $ | 13,000,000 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Non-cash Financing and Investing Activities | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Shares issued in business combination | \u00a0 | $ | 56,320,332 | \u00a0 | $ | - | ||
Issuance of NGW replacement options on acquisition | \u00a0 | $ | 1,239,818 | \u00a0 | $ | - | ||
Lease additions | \u00a0 | $ | 2,972,252 | \u00a0 | $ | 867,559 | ||
Lease terminations | \u00a0 | $ | 371,381 | \u00a0 | $ | - | ||
Fixed Asset Amounts in Accounts Payable | \u00a0 | $ | - | \u00a0 | $ | 363,077 | ||
Warrant liability reclassified to APIC on settlement | \u00a0 | $ | - | \u00a0 | $ | 6,347,946 | ||
Reclassification of long term lease liabilities to current | \u00a0 | $ | 55,588 | \u00a0 | $ | 216,180 |
| \u00a0 | \u00a0 | December 31, | ||||||
Change in Working Capital | \u00a0 | 2022 | \u00a0 | 2021 | ||||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
HST Receivable | \u00a0 | $ | (79,012 | ) | \u00a0 | $ | (56,787 | ) |
Accounts Receivable | \u00a0 | 1,342,487 | \u00a0 | (722,467 | ) | |||
Inventory | \u00a0 | 4,297,897 | \u00a0 | (7,305,529 | ) | |||
Prepaid Expenses and Other Assets | \u00a0 | 167,130 | \u00a0 | (1,780,041 | ) | |||
Long-term Deposits and Other Assets | \u00a0 | 199,334 | \u00a0 | (7,436 | ) | |||
Deferred Tax Assets | \u00a0 | (183,453 | ) | \u00a0 | (162,804 | ) | ||
Accounts Payable | \u00a0 | 127,789 | \u00a0 | 1,578,349 | ||||
Accrued Expenses | \u00a0 | 826,664 | \u00a0 | 4,187,906 | ||||
Income Taxes Payable | \u00a0 | 1,574,807 | \u00a0 | (319,986 | ) | |||
| \u00a0 | \u00a0 | $ | 8,273,643 | \u00a0 | $ | (4,589,077 | ) | |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Cash Paid | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Interest | \u00a0 | $ | 3,720,587 | \u00a0 | $ | 4,485,447 | ||
Income Taxes | \u00a0 | $ | 7,925,000 | \u00a0 | $ | 13,000,000 | ||
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Non-cash Financing and Investing Activities | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
| \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 | \u00a0 |
Shares issued in business combination | \u00a0 | $ | 56,320,332 | \u00a0 | $ | - | ||
Issuance of NGW replacement options on acquisition | \u00a0 | $ | 1,239,818 | \u00a0 | $ | - | ||
Lease additions | \u00a0 | $ | 2,972,252 | \u00a0 | $ | 867,559 | ||
Lease terminations | \u00a0 | $ | 371,381 | \u00a0 | $ | - | ||
Fixed Asset Amounts in Accounts Payable | \u00a0 | $ | - | \u00a0 | $ | 363,077 | ||
Warrant liability reclassified to APIC on settlement | \u00a0 | $ | - | \u00a0 | $ | 6,347,946 | ||
Reclassification of long term lease liabilities to current | \u00a0 | $ | 55,588 | \u00a0 | $ | 216,180 |
| 17. Related Party Transactions and Balances |
\u00a0
\nRelated party transactions are summarized as follows:
\n\u00a0
\na) Building Lease
\n\u00a0
\nThe Company is the sub-lessee of approximately 2,000 square feet of office space and purchases certain printed marketing collateral and stationery items from a company owned by one of the Company\u2019s Co-CEOs. Amounts paid for rent for each of the years ended December 31, 2022 and 2021 was $6,010 and\u00a0$16,027, respectively. Amounts paid for printed marketing collateral and stationery items to the same company were $183,914 and $450,692 for the years ended December 31, 2022 and 2021 respectively. \u00a0
\n\u00a0
\nThe Company leased a cultivation facility from an entity owned by the Company\u2019s co-CEOs.\u00a0 Rent paid for this facility for the years ended December 31, 2022 and 2021 was and $301,894, respectively.\u00a0 On April 30, 2021, the Company\u2019s Co-CEOs sold this building to an arm\u2019s length third party who assumed the lease.
\n\u00a0
\n \n \n(b) Other
\n\u00a0
\nA company owned by one of the Company\u2019s executives pays the Company for storage space.\u00a0 Amounts paid to the Company for storage space were $5,968 and $171,895 for the years ended December 31, 2022 and 2021, respectively, and is recorded in Other Income.
\n\u00a0
\nFor the years ended December 31, 2022 and 2021, no amounts were due to or from related parties.
\n "}]},{"name":"rpt:f-1139","factDimensions":{"xbrl:concept":"us-gaap:AreaOfRealEstateProperty","xbrl:period":"2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"utr:sqft","srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis":"srt:OfficeBuildingMember"},"factValues":[{"value":"2000"}]},{"name":"rpt:f-1140","factDimensions":{"xbrl:concept":"us-gaap:PaymentsForRent","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis":"srt:OfficeBuildingMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"plnhf:CoceoMember"},"factValues":[{"value":"6010"}]},{"name":"rpt:f-1141","factDimensions":{"xbrl:concept":"us-gaap:PaymentsForRent","xbrl:period":"2021-01-01T00:00:00/2022-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis":"srt:OfficeBuildingMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"plnhf:CoceoMember"},"factValues":[{"value":"16027"}]},{"name":"rpt:f-1142","factDimensions":{"xbrl:concept":"us-gaap:PaymentsForRent","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"plnhf:CoceoMember"},"factValues":[{"value":"183914"}]},{"name":"rpt:f-1143","factDimensions":{"xbrl:concept":"us-gaap:MarketingExpense","xbrl:period":"2021-01-01T00:00:00/2022-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"plnhf:CoceoMember"},"factValues":[{"value":"450692"}]},{"name":"rpt:f-1144","factDimensions":{"xbrl:concept":"us-gaap:PaymentsForRent","xbrl:period":"2021-01-01T00:00:00/2022-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis":"plnhf:CultivationFacilityMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"plnhf:CoceoMember"},"factValues":[{"value":"301894"}]},{"name":"rpt:f-1145","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromRelatedParties","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionAxis":"plnhf:StorageSpaceMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"srt:ExecutiveOfficerMember"},"factValues":[{"value":"5968"}]},{"name":"rpt:f-1146","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromRelatedParties","xbrl:period":"2021-01-01T00:00:00/2022-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionAxis":"plnhf:StorageSpaceMember","us-gaap:RelatedPartyTransactionsByRelatedPartyAxis":"srt:ExecutiveOfficerMember"},"factValues":[{"value":"171895"}]},{"name":"rpt:f-1147","factDimensions":{"xbrl:concept":"us-gaap:CommitmentsAndContingenciesDisclosureTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| 18. Commitments and contingencies | \n
\u00a0
\n(a) Construction Commitments
\n\u00a0
\nThe Company had no outstanding construction commitments as of December 31, 2022.
\n\u00a0
\n(b)\u00a0\u00a0\u00a0 Contingencies
\n\u00a0
\nThe Company's operations are subject to a variety of local and state regulation. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company ceasing operations. While management of the Company believes that the Company is in compliance with applicable local and state regulations at December 31, 2022, medical and adult use cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company may be subject to regulatory fines, penalties, or restrictions in the future.
\n\u00a0
\n(c) Claims and Litigation
\n\u00a0
\nFrom time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business. At December 31, 2022\u00a0and\u00a02021, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of the Company\u2019s operations. There are also no proceedings in which any of the Company\u2019s directors, officers or affiliates is an adverse party or has a material interest adverse to the Company\u2019s interest.
\n\u00a0
\n(d) Operating Licenses
\n\u00a0
\nAlthough the possession, cultivation, and distribution of marijuana for medical and adult use is permitted in Nevada, California, Florida and Illinois, marijuana is a Schedule-I controlled substance and its use remains a violation of federal law. Since federal law criminalizing the use of marijuana pre-empts state laws that legalize its use, strict enforcement of federal law regarding marijuana would likely result in the Company\u2019s inability to proceed with our business plans. In addition, the Company\u2019s assets, including real property, cash, equipment, and other goods, could be subject to asset forfeiture because marijuana is still federally illegal.
\n "}]},{"name":"rpt:f-1148","factDimensions":{"xbrl:concept":"us-gaap:LongTermPurchaseCommitmentAmount","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis":"us-gaap:CapitalAdditionsMember"},"factValues":[{"value":"0","decimals":-3}]},{"name":"rpt:f-1149","factDimensions":{"xbrl:concept":"us-gaap:LossContingencyPendingClaimsNumber","xbrl:period":"2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":"0","decimals":-3}]},{"name":"rpt:f-1150","factDimensions":{"xbrl:concept":"plnhf:RiskDisclosureTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| 19. Risks | \n
\u00a0
\nCredit risk
\n\u00a0
\nCredit risk is the risk that a third party might fail to discharge its obligations under the terms of a financial instrument. Credit risk arises from cash with banks and financial institutions. It is management's opinion that the Company is not exposed to significant credit risk arising from these financial instruments. The Company limits credit risk by entering into business arrangements with high credit-quality counterparties.
\n\u00a0
\nThe Company evaluates the collectability of its accounts receivable and maintains an allowance for credit losses at an amount sufficient to absorb losses inherent in the existing accounts receivable portfolio as of the reporting dates based on the estimate of expected net credit losses.
\n\u00a0
\nInterest rate risk
\n\u00a0
\nInterest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates.\u00a0 The Company currently does not carry variable interest-bearing debt.\u00a0 It is management\u2019s opinion that the Company is not exposed to significant interest rate risk.
\n\u00a0
\n \n \nPrice risk
\n\u00a0
\nPrice risk is the risk that the trading price of the Company's shares will fluctuate and result in an increase or decrease in the fair value of the warrant liability. The Company is not exposed to significant price risk.
\n\u00a0
\nLiquidity risk
\n\u00a0
\nThe Company\u2019s approach to managing risk is to ensure that it will have sufficient liquidity to meet liabilities when due.\u00a0 As of December 31, 2022, the Company\u2019s financial liabilities consist of accounts payable, accrued liabilities, obligations under operating leases and taxes.\u00a0 The Company manages liquidity risk by reviewing its capital requirements on an ongoing basis.\u00a0 Historically, the Company\u2019s main source of funding has been the public issuance of common shares.\u00a0 The Company\u2019s access to financing is always uncertain.\u00a0 There can be no assurance of continued access to significant equity financing.
\n\u00a0
\nConcentration risk
\n\u00a0
\nThe Company operates primarily in Southern Nevada and Southern California. Should economic conditions deteriorate within that region, its results of operations and financial position would be negatively impacted.
\n\u00a0
\nBanking Risk
\n\u00a0
\nNotwithstanding that a majority of states have legalized medical marijuana, there has been no change in US federal banking laws related to the deposit and holding of funds derived from activities related to the marijuana industry. Given that US federal law provides that the production and possession of cannabis is illegal, there is a strong argument that banks cannot accept for deposit funds from businesses involved with the marijuana industry. Consequently, businesses involved in the marijuana industry often have difficulty accessing the US banking system and traditional financing sources. The inability to open bank accounts with certain institutions may make it difficult to operate the business of the Company and leaves their cash holdings vulnerable.
\n\u00a0
\nAsset Forfeiture Risk
\n\u00a0
\nBecause the cannabis industry remains illegal under US federal law, any property owned by participants in the cannabis industry which are either used in the course of conducting such business, or are the proceeds of such business, could be subject to seizure by law enforcement and subsequent civil asset forfeiture. Even if the owner of the property was never charged with a crime, the property in question could still be seized and subject to an administrative proceeding by which with minimal due process, it could be subject to forfeiture.
\n\u00a0
\nCurrency rate risk
\n\u00a0
\nAs at December 31, 2022, a portion of the Company\u2019s financial assets and liabilities held in Canadian dollars consist of cash\u00a0of $1,172,859\u00a0(2021 - $165,943). The Company\u2019s objective in managing its foreign currency risk is to minimize its net exposure to foreign currency cash flows by transacting, to the greatest extent possible, with third parties in the functional currency. The Company does not currently use foreign exchange contracts to hedge its exposure of its foreign currency cash flows as management has determined that this risk is not significant at this point in time.
\n\u00a0
\nThe Company\u2019s exposure to a 10% change in the foreign exchange conversion rate at December 31, 2022 equals $117,286.
\n "}]},{"name":"rpt:f-1151","factDimensions":{"xbrl:concept":"us-gaap:Cash","xbrl:period":"2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1172859"}]},{"name":"rpt:f-1152","factDimensions":{"xbrl:concept":"us-gaap:Cash","xbrl:period":"2022-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"165943"}]},{"name":"rpt:f-1153","factDimensions":{"xbrl:concept":"plnhf:SensitivityAnalysisOfForeignCurrencyImpactOf10PercentAdverseChangeInConversionRate","xbrl:period":"2023-01-01T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"117286"}]},{"name":"rpt:f-1154","factDimensions":{"xbrl:concept":"us-gaap:SubsequentEventsTextBlock","xbrl:period":"2022-01-01T00:00:00/2023-01-01T00:00:00","xbrl:entity":"cik:0001813452"},"factValues":[{"value":" \n| 20. Subsequent events |
\u00a0
\nOn February 3, 2023, the Company purchased land and a building in Waukegan, IL for $2,183,000 for its planned Illinois dispensary.
\n\u00a0
\nOn February 7, 2023, the Company purchased the remaining 51% ownership interest in Planet 13 Illinois from a third party for $866,250 cash and the issuance of 1,063,377 common shares of the Company pursuant to an option purchase agreement that was entered into between Frank Cowan, and individual, and the Company on August 4, 2022.
\n\u00a0
\n "}]},{"name":"rpt:f-1155","factDimensions":{"xbrl:concept":"us-gaap:PaymentsToAcquirePropertyPlantAndEquipment","xbrl:period":"2023-02-03T00:00:00/2023-02-04T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"2183000"}]},{"name":"rpt:f-1156","factDimensions":{"xbrl:concept":"us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired","xbrl:period":"2023-02-08T00:00:00","xbrl:entity":"cik:0001813452","us-gaap:BusinessAcquisitionAxis":"plnhf:Planet13IllinoisLLCMember","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"0.51","decimals":2}]},{"name":"rpt:f-1157","factDimensions":{"xbrl:concept":"us-gaap:PaymentsToAcquireBusinessesGross","xbrl:period":"2023-02-07T00:00:00/2023-02-08T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"iso4217:USD","us-gaap:BusinessAcquisitionAxis":"plnhf:Planet13IllinoisLLCMember","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"866250"}]},{"name":"rpt:f-1158","factDimensions":{"xbrl:concept":"us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued","xbrl:period":"2023-02-07T00:00:00/2023-02-08T00:00:00","xbrl:entity":"cik:0001813452","xbrl:unit":"xbrla:shares","us-gaap:BusinessAcquisitionAxis":"plnhf:Planet13IllinoisLLCMember","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"1063377"}]}]}}